Vol 12 No. 3 Summer 2015
Summer 2015
Pharmacy Journal of New England
Vaccine Therapy Strides Forward Rx and the Law: the Wrongful Conduct Rule Customer Satisfaction with Pharmacies: High or Low?
Inside: Register for the New England Pharmacists Convention at Gillette Stadium
Endorsed* by:
Our commitment to quality means you can rest easy. Pharmacists Mutual has been committed to the pharmacy profession for over a century. Since 1909, we’ve been insuring pharmacies and giving back to the profession through sponsorships and scholarships. Rated A (Excellent) by A.M. Best, Pharmacists Mutual is a trusted, knowledgeable company that understands your insurance needs. Our coverage is designed by pharmacists for pharmacists. So you can rest assured you have the most complete protection for your business, personal and professional insurance needs.
Learn more about Pharmacists Mutual’s solutions for you – contact your local field representative or call 800.247.5930:
Tom White
www.phmic.com
PO Box 370 • Algona Iowa 50511
800.247.5930 ext. 7094 508.942.2211
* Compensated endorsement. Not licensed to sell all products in all states.
Pharmacy Journal
Vol 12 No. 3 Pharmacy Journal of New England • Summer 2015
of New England Change is in the Air Dear Readers,
Editors
David Johnson Margherita R. Giuliano, R.Ph., CAE
Managing Editor
It has been said that “when you are through changing, you are through” (Bruce Barton). While change is risky, it also can provide new and exciting opportunities. Pharmacists gain huge opportunities when they are allowed to join health insurance networks. While pharmacists assume more responsibilities as part of the networks, they can be compensated for their services and become formally part of the healthcare team.
Ellen Zoppo CPA
Design & Production Kathy Harvey-Ellis MPhA
In May of this year, Washington State led the way when it became the first state to mandate that health insurance companies include pharmacists as network providers. It is our hope and our goal to work for this positive change in Connecticut and Massachusetts as well.
The Pharmacy Journal of New England is owned and published by the Massachusetts Pharmacists Association and the Connecticut Pharmacists Association. Opinions expressed by those of the editorial staff and/or contributors do not necessarily reflect the views or policies of the publisher.
On the subject of a more immediate change, the New England Pharmacists Convention, to be held September 24-25, has a new home. This annual signature event will convene September 24-25 at Gillette Stadium in Foxborough, MA, home of the New England Patriots.
Readers are invited to submit their comments and opinions for publication. Letters should be addressed to the Editor and must be signed with a return address. For rates and deadlines, contact the Journal at (860) 563-4619.
We’re excited to hold our fall conference in a venue that hosts such a quintessential symbol of fall — football. The quality of the CEs remains very high. We’re eagerly anticipating “Fast Food Pharmacy,” which will share the results from the UConn Working Conditions Survey. (see page 15 for complete details on the entire program).
Pharmacy Journal of New England 35 Cold Spring Road, Suite 121 Rocky Hill, CT 06067-3167 members@ctpharmacists.org
Plus, Ed Sheeran, Passenger, and Christina Perri take the stage at Gillette on Friday, September 25 after the conference. Patriot Place, adjacent to Gillette, boasts plenty of shopping, dining, and nightlife. We’re excited to hold the convention at this area entertainment destination. We hope you are on board for both of these changes in the profession of pharmacy. See you at Gillette! Sincerely,
Submitting Articles to the Pharmacy Journal of New England™ The Pharmacy Journal of New England™ is the product of a partnership between the Connecticut Pharmacists Association and the Massachusetts Pharmacists Association. The Journal is a quarterly publication. All submitted articles are subject to peer review. In order to maintain confidentiality, authors’ names are removed during the review process. Article requirements must conform to the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (Ann Intern Med 1982;96 (1part1):766-71). We strongly encourage electronic submissions. PJNE does not assume any responsibility for statements made by authors.
Please submit manuscripts to: Margherita R. Giuliano, RPh Executive Vice President Connecticut Pharmacists Association
Contents 02
06 14 22 25 26
David Johnson Executive Vice President Massachusetts Pharmacists Association
PJNE 35 Cold Spring Rd., Suite 121 Rocky Hill, CT 06067 or email to: ezoppo@ctpharmacists.org
US News New England States New England Pharmacists Convention Registration Brochure Feature: Vaccine Therapy Strides Forward Pharmacy Marketing Group: Rx and the Law From the Colleges 1
U.S. News FDA Approves Controversial ‘Little Pink Pill’ -- but with Restrictions The Food and Drug Administration has approved a pill that aims to increase a woman’s desire for sex — a controversial decision made only after an extended lobbying campaign by the drug’s makers. But the agencies imposed an unusual number of restrictions on who can prescribe the drug and how they can prescribe it — moves aimed at minimizing concerns over its side effects. The pill’s called flibanserin and will be marketed under the brand name Addyi. The FDA is asking its maker, Sprout Pharmaceuticals, to specially train doctors and pharmacists who dispense it and to keep track of any problems with women taking the drug. Only trained physicians will be allowed to write prescriptions for the pill. The FDA is also requiring a strong warning to women that they should never drink alcohol while taking the drug and stressing the risk that it can cause sudden fainting - a special danger for drivers. The FDA had rejected the drug twice before. Sprout, which bought rights to the drug when pharma giant Boehringer Ingelheim dumped it, helped wage a public relations campaign called “Even the Score.” It claimed that while men have many different sexual dysfunction drugs to choose from, including Viagra and Cialis, women have none. “Today’s approval provides women distressed by their low sexual desire with an approved treatment option,” said Dr. Janet Woodcock, director of the FDA’s Center for Drug Evaluation and Research. Critics said Addyi shouldn’t win approval because of its side effects and because its benefits were modest. But the FDA said there’s no other drug to help women with a severe lack of sexual desire called hypoactive sexual desire disorder. Dr. Susan Wood, a former FDA official now at George Washington University, said she was disappointed by the approval. 2
“This is a product that is neither very effective nor particularly safe,” Wood told NBC News. “It won’t benefit many women and at the same time the approval comes with a lot of restrictions, setting a precedent that a drug for women’s sexual health has to be treated in a very special way,” Wood said. Wood and Dr. Philip Hanno, a urologist at the University of Pennsylvania’s School of Medicine, both say the FDA was pressured into approving the drug. Hanno is one of the FDA advisers who voted against recommending approval of Addyi last June. “I think the FDA was under a lot of pressure,” Hanno told NBC News. “This ‘Even the Score,’ the group which apparently was supported by the pharmaceutical company among others, was very influential and they certainly had a lot of people at the advisory committee meeting who made comments.” The drug is far from being an aphrodisiac. “Hypoactive sexual desire disorder is characterized by low sexual desire that causes marked distress or interpersonal difficulty and is not due to a co-existing medical or psychiatric condition, problems within the relationship, or the effects of a medication or other drug substance,” FDA says. “HSDD is acquired when it develops in a patient who previously had no problems with sexual desire.” In other words, women like Katherine Campbell. Campbell, 31, thinks she could benefit from the drug. “One day I had this great, awesome sex drive and a great relationship with my husband and the next day, I didn’t even think about it any more,” she said. She and her husband Christopher, who live in Indianapolis, noticed the change after their first son was born. “I lost not only a very intimate part of my relationship with my husband, but also a lot of my confidence. My sexuality as a woman changed,” Campbell, who has campaigned for the drug’s approval, told NBC News. Studies show that on average Addyi increased the number of so-called satisfying sexual events by half to one additional event per month over placebo. It doesn’t work like Viagra and other men’s erectile dysfunction drugs. They work by increasing blood flow all over the body, including to the genitals, helping improve a man’s
Pharmacy Journal of New England • Summer 2015
physical ability to have sex. Flibanserin modifies serotonin, a message-carrying chemical in the brain. It’s believed to act over time to increase a woman’s ability to become sexually aroused. “If someone has low sexual desire because they hate their partner, sex hurts and their life is a mess ... the pill is not going to help them,” said Dr. Lauren Streicher of Northwestern University. “This is a huge advancement in women’s health because for the first time we have an FDA-approved, nonhormonal option for women who have this very distressing lack of sexual desire,” Streicher said. “And as a sexual health expert, as a gynecologist, as someone who takes care of women every single day ... this is going to be a game changer for me because right now I have women that come into my office and have these issues and I just say, ‘I’m so sorry. There is nothing that I can do.’” The company says it will aim to price Addyi to compare to the cost of Viagra. They anticipate it will probably be covered by health insurance companies with a co-pay of $30 to $75. Sprout says it should become available in October http://www.nbcnews.com/health/sexual-health/fda-approves-controversial-femaleviagra-restrictions-n412116
Policy Brief Pushes for OTC Birth Control Making birth control available OTC would improve women’s access to oral contraceptives while producing dramatic cost savings, a new National Center for Policy Analysis (NCPA) brief argues. Beginning in January 2016, pharmacists in Oregon will be authorized to dispense transdermal and oral contraceptives without a prescription to women 18 years and older. At the federal level, Senators Kelly Ayotte (R-NH) and Cory Gardner (R-CO) have introduced Senate Bill 1438, the “Allowing Greater Access to Safe and Effective Contraception Act,” which would permit oral contraceptives to be sold OTC nationally.
while 86% were either “strongly in favor” or “somewhat in favor.” Planned Parenthood and the American College of Obstetricians and Gynecologists (ACOG) also support the idea of OTC birth control, but they oppose S. 1438 because the proposal does not include cost-reduction measures and it narrowly refers to the birth control pill. To address their latter point, ACOG and Planned Parenthood argued that long-acting reversible contraceptives such as intrauterine devices (IUDs) are the most effective contraceptives. By providing OTC oral contraceptives, they asserted, women will wind up paying more for less-effective forms of birth control. Yet, recent estimates from the US Centers for Disease Control and Prevention show that women already prefer birth control pills over long-acting reversible contraceptives. CDC data from 2011 to 2013 suggest that 16% of women using a contraceptive method take the pill, which is more than double the 7.2% of women with long-acting reversible contraceptives. In terms of costs, ACOG and Planned Parenthood noted that S. 1438 would eliminate the no-co-pay contraceptive mandate of the Affordable Care Act, which they believe would make contraceptives unaffordable for millions of women. However, the NCPA pointed out, transitioning birth control to OTC would lower prices precipitously and result in dramatic cost savings, as was seen when proton pump inhibitors made the jump from prescription to OTC. Additionally, estimates from the Consumer Healthcare Products Association suggest that consumers save between $6 and $7 in prescription costs in unnecessary physician visits for every $1 spent on an OTC product. Given that 54,000 pharmacies in the United States offer prescription drug services, while 700,000 retail outlets sell OTC products, S. 1438 would greatly improve access to birth control for the 7 million US women who use oral contraceptives, the NCPA concluded. See more at: http://www.pharmacytimes.com/resource-centers/womens-health/policybrief-pushes-for-otc-birth-control#sthash.4WQ6UgCX.dpuf
The concept has wide-scale support. A May 2015 survey by Ibis Reproductive Health found that more than 50% of respondents, including health care providers and academic researchers, were “strongly in favor” of OTC birth control, 3
U.S. News
continued
Modern malady may be behind rise in dementia Could pollution be to blame for why dementia is killing more people and being diagnosed earlier than ever? That’s the theory being floated by researchers involved in a study of patients in 21 countries from 1989 to 2010. The Smithsonian reports that while dementia is typically associated with people older than 60, the study finds that diseases such as Alzheimer’s are now being regularly diagnosed in people in their late 40s. Death rates, too, are rising, particularly in the US, where American men over 75 are three times as likely and American women five times as likely to die from neurological disease than they were 20 years ago, notes the Washington Post. So what is it about modern life that’s causing what researchers label a “hidden epidemic”? Lead author Colin Pritchard of Bournemouth University has a hunch. “The environmental changes in the last 20 years have seen increases in the human environment of petro-chemicals—air transport—quadrupling of motor vehicles, insecticides and rises in background electro-magnetic-field, and so on,” he writes. Researchers admit part of the increase could be explained by better treatments for cancer and heart disease, which used to kill elderly people before dementia could. But, they argue that neither this, nor aging populations and better diagnoses, could entirely account for such a steep increase. Researchers say this is a wake-up call to make environmental changes, but not everyone is so sure. One doctor tells the London Times, which first reported on the study, that dementia is a complicated disease that could be caused by a “complex interplay” of factors. (Simple memory and thinking tests may provide a clue about what’s in store for people nearly 20 years down the road.) http://www.newser.com/story/211357/modern-malady-may-be-behind-rise-in-dementia.html
Can Coffee Lower Risk of Colon Cancer’s Return? Colon cancer patients who regularly drink caffeinated coffee may be lowering their risk of tumor recurrence and death from the disease, new research suggests. But researchers added that it’s premature to tell patients to drink coffee to reduce their risk of the cancer’s return. 4
The study found that people with advanced (stage III) colon cancer who drank four or more cups of caffeinated coffee every day had 52 percent lower odds of disease recurrence or cancer death compared with coffee abstainers. Even people who regularly drank slightly less (two to three cups) per day appeared to reap some of the same benefits, just to a lesser degree. “There is already an abundance of evidence that diet and lifestyle can have a great deal of positive impact in terms of reducing the risk for developing colon cancer,” explained study lead author Dr. Charles Fuchs, director of the Gastrointestinal Cancer Center at the Dana-Farber Cancer Institute in Boston. “Now we have found that caffeinated coffee seems to independently improve the outcome for colon cancer patients,” he said. It’s important to note, however, that this study was only designed to find an association between coffee consumption and a lower risk of colon cancer recurrence or death from colon cancer. It wasn’t designed to prove a cause-and-effect relationship. The study findings were released online August 17 in the Journal of Clinical Oncology. To explore coffee’s impact on colon cancer, the research team focused on roughly 950 people with stage III colon cancer. They all completed nutrition questionnaires while undergoing postsurgical chemotherapy treatment at some point between 1999 and 2001. Dietary information was collected again six months after completion of chemotherapy. The study volunteers were asked about more than 130 different food and drink items. Those items included caffeinated coffee, decaffeinated coffee and non-herbal (caffeinated) tea. In turn, cancer recurrence and patient death rates were followed for an average of a little more than seven years. Cancer returned in 329 people, mostly within five years of initial treatment, the study found. Of these, 288 died of their disease. An additional 36 people who didn’t have a diagnosis of a cancer recurrence also died during the study follow-up. So is caffeine the magic bullet?
Pharmacy Journal of New England • Summer 2015
“For one, we really had too few patients drinking decaf coffee or non-herbal tea to really say what their specific impact might be,” acknowledged Fuchs. “And it is also true that coffee has a lot of components in addition to caffeine that could possibly be relevant to colon cancer,” he added. “But I do think it would be reasonable to conclude that it could be the caffeine in coffee that is affecting the colon cancer pathway,” Fuchs said. “It’s just that for now we can’t say for sure. We need to confirm these findings in other patient populations.” But, Fuchs said he wouldn’t promote coffee to patients who aren’t already fans. “If patients are already drinking coffee regularly I would certainly say go ahead and continue to do so,” he said. “But we need to look at this some more. And meanwhile, there are plenty of healthy lifestyle choices that can help, including avoiding obesity, avoiding a high-carb diet, and avoiding sugary beverages, to name a few.” That advice was seconded by Dr. Andrew Chan, an associate professor in the department of medicine at Harvard Medical School, and an associate professor of medicine in the department of gastroenterology at Massachusetts General Hospital in Boston. “I think to some extent telling patients to go start drinking coffee would be a premature recommendation,” Chan said. “Yes, this was a carefully done study that does suggest that coffee certainly isn’t harmful, and there’s certainly some value for patients. But I’m not sure that the apparent benefit of coffee is clear enough yet to warrant any clinical recommendations. That will require additional research to establish direct causality,” Chan added. Read more at http://www.philly.com/philly/health/cancer/HealthDay702361_20150817_ Can_Coffee_Lower_Risk_of_Colon_Cancer_s_Return_.html#zWzyYlsCSZeGKSdf.99
Customer Satisfaction with Pharmacies Remains Stable Despite Changes in Healthcare Industry Despite all of the changes in the healthcare industry, customer satisfaction with pharmacies has remained relatively stable, according to the J.D. Power 2015 U.S. Pharmacy
StudySM released today. The study, now in its ninth year, measures customer satisfaction with brick and mortar—which includes chain drug stores, mass merchandisers and supermarkets—and mail order pharmacies. Satisfaction with brick and mortar pharmacies is measured across five factors: prescription ordering; store; cost competitiveness; non-pharmacist staff; and pharmacists. Satisfaction with mail order pharmacies is measured across four factors: cost competitiveness; prescription delivery; prescription ordering process; and customer service experience. Satisfaction is calculated on a 1,000-point scale. Overall satisfaction with supermarket pharmacies improved to 851 in 2015, up from 843 in 2014, while satisfaction with chain drug store pharmacies improved by 2 points to 842. Satisfaction with mail order pharmacies dropped by 2 points to 820, and satisfaction with mass merchandiser pharmacies dropped to 822 from 830. “The healthcare industry has undergone tremendous changes in recent years, and more changes are coming, so stable customer satisfaction with pharmacies is very positive,” said Rick Johnson, director of the healthcare practice at J.D. Power. “Pharmacies serve as a benchmark for other entities in the healthcare ecosystem, as they continue to have the highest levels of customer satisfaction in the healthcare industry, demonstrating that focusing on customer satisfaction is good for both patients and businesses.” Pharmacists and pharmacy staff play a critical role in customer satisfaction. The study finds that the simple step of asking customers if they would like to speak with a pharmacist causes overall satisfaction to improve by 54 points. In addition, when customers perceive their conversations are handled with discretion and a private area for discussions is provided, satisfaction improves by 99 points. Moreover, customers who speak with a pharmacist are significantly more likely to purchase other items from the pharmacy and demonstrate higher loyalty rates. While 44 percent of customers who speak with a pharmacist “strongly agree they feel loyal to their pharmacy,” only 35 percent of those who do not speak with a pharmacist say the same. Read more: http://www.news-medical.net/news/20150824/ Customer-satisfaction-with-pharmacies-remains-stable-despitechanges-in-healthcare-industry.aspx
5
New England States Connecticut
The one-hour talk will include why metrics are utilized in pharmacies; identifying the different types of metrics that are seen in community pharmacy practice as well as determining which metrics, if any, are most likely to impact patient safety. As part of the talk, there will also be an open discussion on potential solutions to ensure patient safety in community pharmacies.
President’s Message Dear CPA Members,
We are getting excited for the New England Pharmacists Convention,
Karen Hoang
to be held September 24-25 at Gillette CPA President Stadium in Foxborough, MA. I’d like to point out a specific session that I believe will be of great interest to our membership.
Following the Convention CE, the CPA will disseminate the report to members and also continue working with the Pharmacy Commission on an appropriate plan of action to address these issues. For more information or to register, please click here to visit the New England Pharmacists Convention website.
The data from the Workplace Survey that was commissioned by the Connecticut Pharmacists Association will be a featured CE program at the convention. As many pharmacists are aware, an anonymous and secure survey was disseminated to pharmacists last year in response to concerns raised by community pharmacists about their working conditions, increased emphasis on metrics, and a decreased sense of patient safety. The survey results have been reviewed by CPA staff and received by the Pharmacy Commission Task Force subcommittee members, who also met privately last spring with a small group of community pharmacists from the chains operating in the state. The report’s findings will be unveiled at the New England Pharmacists Convention Friday morning, September 25, 2015 with a CE talk by Dr. Lauren Schlesseman entitled “Fast Food Pharmacy: Is Your Workload Putting Your Patients at Risk?”
Dr. Lauren Schlesseman, PharmD, MA
6
Visit www.nepharmacists.org to learn more and register for the convention!
Pharmacy Journal of New England • Summer 2015
Massachusetts
Commission and requires a pharmacist to dispense: “an interchangeable abuse deterrent product if one exists; or, if none exists, a less expensive, reasonably available, interchangeable drug product as allowed by the most current formulary or supplement thereof.”
Helping Pharmacists to Help their Patients:
Baker’s working group released its new recommendations in late June. MPhA supports the recommendations; here are just a few we think are great:
President’s Message
The Opioid Epidemic The news headlines tell it all: the incomprehensible deaths of healthy individuals in their 20s – sadly, no longer Susan Holden such unusual occurrences. Babies MPhA President born to opioid-addicted mothers, whisked into the NICU for days of harrowing withdrawal. And the shocking news story recently published in the New York Times, describing impoverished, recovering drug addicts who often deliberately relapse and begin new drug treatment programs – just to keep a roof over their heads by allowing their unscrupulous landlords to pocket the Medicaid kickbacks from their revived substance abuse treatment. All of the above scenarios show that the opioid epidemic, which in the past had been seemingly contained to the periphery of society, has now become everyone’s problem. According to a report cited by Mass.gov, nearly 4 in 10 residents of Massachusetts know someone who has misused prescription drugs within the past five years. There are 17 branches of the state-wide, peer-led support group Learn to Cope – and each one holds weekly meetings. More than 6500 residents of Massachusetts have died from opioid overdoses in the past 11 years. Given the scope of the crisis, the Massachusetts Pharmacists Association applauds Governor Charlie Baker for convening a working group focused on the epidemic. The Baker work group recommendations follow on the heels of several measures adopted by the state’s legislature and Patrick administration in the past few years, including the passage of Chapter 258 of the Acts of 2014, which established the Opioid Drug Formulary
Provide state funding for evidence-based opioid prevention programs in school. Although “Just Say No,” First Lady Nancy Reagan’s anti-drug campaign from the 80s, now seems almost wildly simplistic, it made an impact in educating young people about the dangers of drugs. Recreational drug abuse declined during the Reagan administration. (Benze, James G., 2005). Hopefully, if a child learns about the dangers of opioids from an early age, he or she will be less likely to start using and get hooked. Improve affordability of Naloxone through bulk purchasing. Since Naloxone sprung into widespread use in Massachusetts starting early last year, it has reversed hundreds of potentially fatal opioid overdoses. (It is, after all, known as the “rescue drug.”) It is crucial to keep Naloxone as affordable as possible. Certify and register alcohol and drug-free housing to increase accountability and credibility. In order to maintain sobriety, addicts need to live in a safe place. If they return to their previous living situation, they often use again. The creation of more specialized housing for addicts will be an important step in their recovery. Encourage the American College of Graduate Medical Education to adopt requirements for pain management and substance use disorder education. A recent survey by the Johns Hopkins School of Public Health revealed that physicians are surprisingly uninformed about opiate abuse, and many are unable to identify the most common manner in which opioids are abused (pharmacytimes. com). In addition, doctors from the VA Medical system violated the agency’s own rules when they prescribed opiates over too long a timeframe or in conjunction with 7
New England States
continued
benzodiazepines — a mix that has proven fatal in far too many cases (nbcnews.com). While this education requirement would require state legislation, it could be well worth the effort. As the prescribers, doctors need to be informed of the dangers of opiates, as well as the benefits. As Massachusetts starts to implement these and other recommendations, MPhA wants to ensure that pharmacists join the medical community on the “front lines” of the war against opioid addiction – and that they are armed with the tools they need. Pharmacists, who assume such responsibility when dispensing opiates, must be supported. Here are a few ideas to help make this happen: Gov. Baker’s working group recommended that the Prescription Monitoring Program be improved to ensure data compatibility with other states. MPhA endorses this. “It is important that Massachusetts join the 29 other states that are actively sharing PMP data,” says Karen Ryle, RPh, MS and member of MPhA, “This is particularly important for pharmacies bordering another states, where ‘doctor shopping’ may occur.” In addition, the working group proposed that legislation be filed to require pharmacists to submit data to the state’s Prescription Monitoring Program (PMP) within 24 hours of receipt. In theory, this sounds great. Yet, as we know, not all pharmacies are created equal – or at least, not equal in terms of resources and manpower. It will be more difficult for smaller independents than large chain pharmacies to keep on top of the additional workload, for example. Perhaps this new requirement could be rolled in gradually, until all employees are trained. The workgroup also recommended that addiction specialists be installed to the state medical boards of medicine, nursing, physician assistants, and dentistry. But what about the Board of Pharmacy? The Board regularly takes up such issues as controlled substance security and diversion. An addiction specialist could add a valuable perspective to the Board. Pharmacists need to learn all they can about the patterns of addicts if they are to combat diversion and other crimes that occur in pharmacies. 8
Finally, in the call for regulation over opioid prescribing, MPhA encourages a balanced approach. With the increased awareness of the dangers of addiction, legitimate prescriptions can be harder for patients to fill. Recently, a patient contacted MPhA because he had difficulty securing his prescription from the pharmacy, and felt like he was treated “like a criminal” by a pharmacist. While checks and balances on opioid prescriptions are undoubtedly necessary, a little sensitivity by prescribers and dispensers can go a long way for patients. MPhA supports Gov. Baker’s working group and applauds its recommendations. We know the opioid epidemic has hurt too many families and ravaged too many lives. As medical professionals, pharmacists want to do their part — and we stand ready.
MPhA Board Secretary Joanne Doyle Petrongolo, PharmD Joins Drug Commission MPhA Board Secretary Joanne Doyle Petrongolo is participating in the Mass Opioid Drug Formulary Commission, a group that will recommend whether drug products will be placed on the Mass Additional List of Interchangeable Drugs. The Commission will do this by assessing drugs in the powerful opioid class.
MPhA Foundation Honors Student Leaders at Spring Conference The MPhA Foundation awarded four $1000 scholarships to students from each of Massachusetts’ four pharmacy schools at MPhA’s Spring Conference on April 30, 2015. The Foundation is pleased to announce the following scholarship recipients: Nicole Dutton - Western New England University College of Pharmacy Nestor Otero - Western New England University College of Pharmacy Amit Hirani - MCPHS-Boston Katie Alfond - Northeastern University, Bouvé College of Health Sciences School of Pharmacy
Pharmacy Journal of New England • Summer 2015
New Hampshire MCPHS-Manchester Advocates for Provider Status Bill Faculty and students from the MCPHS-Manchester campus met with NH delegates of the US Congress to advocate for the federal provider status bills. Kristine Willett and Jennifer Towle (also board members of the New Hampshire Society of Health-System Pharmacists) and Cheryl Durand (New Hampshire Pharmacists Association Board member) along with PharmD students Elizabeth Lagasse, Katharine Jones, Peter Caikauskas, Regan Sevinsky and Lejla Kadic met with staff members of Senator Ayotte and Shaheen’s office and with Representative Frank Guinta.
Student, Faculty and pharmacists met with Congressman Guinta. (above)
___________________________________________________________________________________________________________
Pharmacy Students Meets Staffers on Capitol Hill By Jessica Marx
Above, pictured from left to right: Mallory Moore – Presbyterian University, Alexandria May – Medical University of Southern Carolina, Wanda Azu Owoh – Hampton University, Allie Jo Shipman – Mercer University and Jessica Marx – MCPHS University.
Earlier this month, I had an amazing opportunity to meet with the staffers of our state representatives on Capitol Hill while I was in DC for APhA’s Summer Leadership Institute. I met with staffers from the offices of Senator Shaheen, Senator Ayotte and Representative Guinta and spoke with them regarding the Pharmacy and Medically Underserved Areas Enhancement Act (S.314 and HR.593). These bills in both the Senate and House would grant us reimbursement via Medicare Part B for the many services our profession is able to offer in medically underserved areas throughout the state (aka Provider Status). If you haven’t already, support the campaign by visiting www.pharmacistsprovidecare.com.
9
New England States
continued
Stakeholder Input Key to Developing New Opioid Prescribing Guidelines US Senators Joe Donnelly (D-IN) and Kelly Ayotte (R-NH) sent a letter to the US Department of Health and Human Services (HHS) Secretary Sylvia Burwell urging the Center of Disease Control and Prevention (CDC) to continue soliciting feedback from key stakeholders when crafting new guidelines and best Practices for prescribing opioids. Donnelly and Ayotte also applauded Secretary Sylvia Burwell for her commitment to addressing opioid abuse. Donnelly and Ayotte have been working together to combat the opioid abuse and heroin use epidemics through the Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act, which they reintroduce this past April. Their bill includes a provision calling for the development of best practices for opioid prescribing.
New Hampshire Legislative Update By Elizabeth C. Sargent & Lorraine E. Radick There were a number of key bills that affected pharmacists in the 2015 NH legislative session which are as follows: Collaborative Practice A bill requested by pharmacists, HB 190, establishing a statutory commission to study the standards for collaborative pharmacy practice, was signed into law on July 6. There are many stakeholders who will participate in the review of the current collaborative practice statute and the possibility of expanding the scope of pharmacy practice. Cheryl Durand, NHPA VicePresident, will serve on the commission representing NHPA. Workload Issues Another bill, requested by the NH Pharmacists Association, was House Bill 141, relative to rulemaking authority concerning practice standards and safe and secure operation of pharmacies. The bill passed the House and is being held in the Senate Executive Departments and Administration Committee for further study. Senator Carson felt that the implications of a recently released audit of the Board of Pharmacy would have a direct impact on this bill. Therefore, she suggested
10
re-referring the bill to Committee, and asking for a letter from the Board of Pharmacy in January to see where they are on correcting the deficiencies noted in the audit report. This bill would give the Board of Pharmacy rulemaking authority to adopt rules around workload issues. If there is no action by the Board, the Committee will look at drafting a specific bill regarding working conditions that would put it into statute instead of rulemaking authority. All of the Senators are committed to doing something and will not let this issue die. Compounding To comply with new federal standards, SB 202 –FN, Relative to licensure of outsourcing facilities by the pharmacy board, was requested by the NH Board of Pharmacy. The bill establishes the requirement for licensure by the pharmacy board of outsourcing facilities operating pursuant to section 503B of the Federal Food, Drug, and Cosmetic Act. It was signed into law by the Governor on June 26, 2015. Immunization Registry NH is the only state that does not have an immunization/ vaccination registry that is currently active. House Bill 383, Relative to the immunization/vaccination registry, was introduced to clarify certain options relating to the immunization/ vaccination registry and exempt the registry from the right-to-know law. The bill had many objections from Senators who are concerned about privacy and the collection of personal data by the government. The bill was re-referred to the Senate Health and Human Services Committee for further study. Prescription Monitoring Program The Prescription Monitoring Program continues to be improved upon. Senate Bill 31, Relative to the controlled drug prescription health and safety program, makes improvements to the controlled drug prescription health and safety program, including clarifying the registration process and confidentiality procedures. The bill also establishes a committee to study certain issues relative to the controlled drug prescription health and
Pharmacy Journal of New England • Summer 2015
safety program. The committee’s study shall include, but not be limited to, considering whether and under what conditions there should be a requirement to utilize the system before prescribing any schedule II-IV controlled drugs. Senate Bill 31 was signed by the Governor in May 21, 2015. House Bill 483—Relative to the commission on primary care workforce issues This bill extends the commission on primary care workforce issues. The commission shall plan and advocate for policy changes related to maintaining and strengthening an effective primary care workforce in New Hampshire, with special concern for rural and other underserved areas. This bill also adds new members to the commission and clarifies its duties. HB 483 was signed by the Governor on July 13, 2015. Christopher Lopez, NHPA President-Elect, has submitted his name to the NH Board of Pharmacy for consideration to be the pharmacist representative. 700 Rules: Joint Legislative Committee on Administrative Rules (JLCAR) approved the 700 rules on July 16, 2015 -updating the standard of practice rules. Included in these rules is a new requirement for Pharmacists who are looking to serve as a Pharmacist-in-Charge (PIC). They must have worked as a pharmacist for a minimum of 2 years post-graduation, and also complete and pass and exam with a minimum of 80%. This exam is designed by the board to assess the knowledge of the candidate in regard to their responsibilities as a PIC. The exam must be taken before December 31, 2015. The NH Board Pharmacy will be publishing additional details on their website relatively soon. Pharmacists may serve as a PIC for a maximum of two pharmacies, providing that one of these pharmacies shall be in an institution requiring the services of a pharmacist only on a part-time basis. They must work a minimum of 20 hours per week at the location where he/she serves as a PIC, except when absent due to scheduled vacation or other authorized leave.
summer, and as a result, a bill was passed to prohibit the sale, use or possession of synthetic drugs in NH. The Governor’s Commission on Alcohol and Drug Abuse Prevention, Treatment, and Recovery shall prepare a report, including recommendations for policies to be implemented for coordinating public awareness of and education in the dangers of synthetic drugs and other emerging or designer synthetic drug substances. This bill was sponsored by Senator Molly Kelly and others. SB 106 was signed by the Governor on July 2, 2015 and is effective immediately. Naloxone — HB 271 — An Act relative to possession and administration of an opioid antagonist for opioid-related overdoses. A healthcare professional authorized to prescribe an opioid antagonist may prescribe, dispense or distribute, directly or by standing order, an opioid antagonist to a person at risk of experiencing an opioid-related overdose or a family member, friend, or other person in a position to assist a person at risk of experiencing an opioid-related overdose. This bill was signed by the Governor on June 2 and takes effect immediately.
2015 Continuing Education Conferences: On May 20, NHPA held its fifth annual CE program at the Grand Summit Hotel in Bartlett, New Hampshire. In addition to the vendor exhibits, we had six pharmacy students from MCPHS University (MHT campus) who presented posters during the afternoon break. Their topics included: “Management and Treatment of Hepatitis C: A Comparison of Emerging Drug Therapies” -Andrew Booth and Emmaline Clarkson “Recently approved Antibiotics in the Face of Resistance”Vanya Chan and Helen Chim “Kids Corner: Do you Know Your OTC Facts?”-Megan Januszewski and Travis Paige
Remaining CE Conferences for 2015 September 13, 2015 & December 6, 2015
Synthetic Marijuana—Senate Bill 106-FN
SERESC, Bedford, NH
The issue of synthetic marijuana came to a crisis point last
Details can found on our website at www.nhpharmacists.net. 11
New England States
continued
Maine Maine Pharmacy Association Advocates for Provider Status: HR 592/S314 HR 592/S314 “Pharmacy and Medically Underserved Areas Enhancement Act” is one of the most important legislative initiatives for the profession of pharmacy. HR 592 and the Senate companion bill S314 would amend Title XVIII of the Social Security Act to include pharmacists as providers thereby enabling patient access to, and payment for pharmacy services. Currently, there are 185 cosponsors in the House of Representatives for HR 592 and 28 cosponsors of S314 in the Senate. Representative Pingree and Senator Collins have already pledged their support to the bill. ecently, a delegation from Maine Pharmacy Association met with legislative staff at Representative Poliquin’s office in Lewiston to advocate for this important legislation. The visit concluded by asking Representative Poliquin to support patient access to cost-effective pharmacy services and to cosponsor HR 592. The MPA delegation will be meeting with Senator King’s office later this month.
Above, from left to right: : Kenneth McCall, PharmD, Associate Professor UNE, Cassandra White, PharmD, Assistant Professor, Husson University, Amelia Arnold, PharmD, Manager of Retail and Clinical Operations, Community Pharmacies, Erin Kany, UNE Class of 2017, Stephanie Lewis, PharmD, UNE-Hannaford Pharmacy-Martin’s Point Healthcare PGY1 Resident, Jacob Turmel, Husson Class of 2016, and Minh Pham, UNE Class of 2016.
___________________________________________________________________________________________________________
MPA Fall Convention and Award Banquet The Maine Pharmacy Association Fall Convention and Trade Show has lined up outstanding speakers to educate our pharmacy community on topics relevant to the profession. Also included in the continuing education option is CPR recertification. The convention is scheduled to run from September 11-13, 2015 at the Hollywood Casino, Bangor,
12
Maine with our annual awards ceremony being held on Saturday, September 12. For more information please visit MPARX.com.
Pharmacy Journal of New England • Summer 2015
Rhode Island Congratulations to our newly elected Officers and Council of Administration! The 2015-2016 RIPA Officers and Council, whose terms began on July 1st, are looking forward to working hard for you, our valuable members, over the coming year!
Administration members in the Spring! •
$5,000 winner: John Stergio
•
$1,000 winner: Michael Ira Smith
•
$500 winner: Chip Eckloff
•
$250 winner: Hector Derreza
•
$250 winner: Daniel Lefkowitz
•
$250 winner: Matthew Dodge
•
President: Lynn Pezzullo
•
President-Elect: Sarah Thompson
•
Past-President: Anita Jackson
•
Treasurer: John Grossomanides
•
Secretary: Lucrezia Finegan
•
Council Members:
o
Nicole Asal
o
Tom Kalista
o
Christopher Federico
Be sure to register now for the New England Pharmacists Convention in Foxborough, MA and for our 141st RIPA President’s Dinner and Awards Ceremony on Thursday, September 24th, 2015. At the RIPA Dinner at 7:30pm at the nearby Renaissance Hotel at Patriot Place, we will formally install our new Officers and Council of Administration, and recognize the achievements of our 2014-2015 RIPA leadership teams. The Awards Ceremony will highlight the outstanding contributions of many talented and dedicated pharmacists and pharmacy supporters across Rhode Island:
o
Daniel Lefkowitz
• RIPA Presidential Leadership: Anita N. Jackson, Pharm.D.
o
Christine Eisenhower
• NCPA Pharmacy Leadership: Lynn M. Pezzullo, RPh, CPEHR
o
Ginger Lemay
• McKesson Incoming President: Lynn M. Pezzullo, RPh, CPEHR
In RI Legislative news, the long anticipated CLIA bill, allowing pharmacists to perform over-the-counter limited function blood tests, was signed into law by Governor Raimondo in July. This will allow pharmacists to expand the information provided to patients during medication therapy management sessions, screen for important chronic disease states, and enhance communication and collaboration between community pharmacies and primary care providers.
• Bowl of Hygeia: Deborah S. Newell, RPh, CDOE, CVDOE
Our 17th Annual RI Pharmacy Foundation Golf Outing at Laurel Lane was a success, drawing golfers from across the state in spite of some rain! We were successful in raising funds for important scholarships to support student pharmacists, our future pharmacy leaders. We look forward to planning and sharing all the details for our 18th Annual Golf Outing, including a new venue, in the Spring of 2016.
• RIPA Pharmacist Service: Lucrezia Finegan, RPh, MBA
Congratulations to our 2015 RIPA raffle winners! The lucky raffle winners are drawn at the Golf Outing each year, with no more than 250 tickets available for sale. If you missed out on buying a wining ticket this year, be sure to be on the lookout for ticket sales from any of your RIPA Officers and Council of
• Distinguished Young Pharmacist: Christopher L. Federico, PharmD, CDOE, CDE, BCACP • Excellence in Innovation: Stephen J. Kogut, PhD, MBA, RPh • Guido L Pettinichio: Tara Higgins, PharmD • Cardinal Health Generation Rx: Jeffrey Bratberg, PharmD, BCPS
• RIPA Professional Service: Denise Gorenski, M.Ed. • RIPA Student Service: Patricia “Geri” Buderwitz, PharmD Candidate • Charles Hachadorian, Jr Award: Dr. Paul George, MD We welcome you to attend Council of Administration meetings. This is a great year to get involved in RIPA through active committee participation and event attendance. If you are not yet a member of RIPA, please consider joining today ( ripharmacists.org ).
13
11th Annual New England Pharmacists Convention September 24 & 25, 2015
Putnam Club East, Gillette Stadium, Foxborough, MA
Registration Information
Presented By The Connecticut Pharmacists Association, The Massachusetts Pharmacists Association, The New Hampshire Pharmacists Association, & The Rhode Island Pharmacists Association www.nepharmacists.org info@masspharmacists.org
New England Pharmacists Convention 500 W. Cummings Park, Suite 3475 Woburn, MA 01801
14
Gillette Stadium in Foxborough Home of the Super Bowl Champion New England Patriots !
Schedule of Events September 24, 2015 7:30 a.m. – 8:00 a.m. Certificate Program Registration & Continental Breakfast 8:00 a.m. – 5:00 p.m. NEW! Pharmacy-Based Cardiovascular Disease Risk Management Certificate Training Program 8:00 a.m. – 5:00 p.m. Delivering Medication Therapy Management Services Certificate Program 8:00 a.m. – 5:00 p.m. The Pharmacist and Patient-Centered Diabetes Care Certificate Training Program 12:00 p.m. – 1:00 p.m. Convention Check In & Registration Regular Programming Begins at 1:00 p.m. 1:00 p.m. – 2:00 p.m. Balancing Patient Needs Against Challenging Regulations: How to Obtain Best Outcomes ACPE: 0106-9999-15-009-L03-P; 0106-9999-15-009-L03-T
Presented By: Chuck Young, RPh, CFE, Senior Associate for Regulatory Affairs & Compliance, & Lori A. Bassinger, R.Ph., J.D.
photo courtesy of Atlanticrecords.com
Grammy-nominated recording star
Ed Sheeran performs at Gillette Stadium the night of September 25 following the conference Buy concert tickets via the attached registration form!
Upon completion of this activity, participants should be able to: 1. Describe how DEA regulations hold pharmacists to a corresponding responsibility with prescribers of controlled substances to ensure a prescription is issued for a legitimate medical purpose. 2. Identify red flags that may appear when a patient presents with a prescription for a controlled substance. 3. Distinguish prescriptions that are being issued for a legitimate medical purpose from those that are not. 4. Describe risk management strategies to deter controlled substance losses and to create a culture of safety in the dispensing of controlled substances. 2:05 p.m. – 3:05 p.m. Attention Deficit Hyperactivity Disorder in Children: What Should Pharmacists Focus On? ACPE: 0106-9999-15-036-L01-P
Presented by: Chandra K. Cooper, PharmD, BCPP, Senior Clinical Specialist, Psychiatry, Director, PGY2 Psychiatric Pharmacy Residency Yale-New Haven Hospital Upon completion of this activity, participants should be able to: 1. Describe the prevalence, core symptoms and diagnostic criteria for childhood ADHD. 2. Compare and contrast ADHD treatment options focusing on efficacy, tolerability and available dosage forms.
15
Putnam Club East at Gillette Stadium, September 24 and 25, 2015 3. Develop and individualize an ADHD treatment regimen taking into consideration patient age, co-morbid conditions and drug interactions. 4. Counsel children and caregivers about ADHD treatment goals and expectations. 3:05 p.m. – 3:20 p.m. - Break 3:20 p.m. – 4:20 p.m. Insights, Pearls, and Perspectives - An Update in the Management of Chronic Obstructive Pulmonary Disease ACPE: 0106-9999-15-036-L01-P
Presented by: Nicole Asal, PharmD, BCPS, Clinical Assistant Professor, University of Rhode Island College of Pharmacy Upon completion of this activity, participants should be able to: 1. Review the most recent upddates to the 2015 GOLD guidelines. 2. Describe new guidelines for Asthma COPD Overlap Syndrome (ACOS). 2. Review the most recent evidence on new and emerging COPD medication regimens. 3. Discuss benefits of and opportunities for pharmacist intervention in patients with COPD. 4:25 p.m. – 5:25 p.m. Pharmacy Robbery: When it Happens to You ACPE: 0106-9999-15-008-L04-P; 0106-9999-15-008-L04-T
Presented by: Karen Horbowicz, PharmD, Alessandra Baran, PharmD, James Scanlon, R.Ph. Upon completion of this activity, participants should be able to: 1. Define diversion and provide examples of how medications can be diverted. 2. Identify ways to improve your safety while working in a pharmacy setting. 3. Formulate an armed robbery plan for your place of work. 4. Identify post-robbery coping strategies for pharmacy personnel.
16
5:20 p.m. – 6:00 p.m. Convention Cocktail Reception
9:25 a.m. – 10:25 a.m. “Fast Food Pharmacy”: Is Your Workload Putting Your Patients at Risk?
7:30 p.m. – 9:30 p.m. CPA Annual Installation and Awards Banquet Dinner MPhA Annual Installation and Awards Banquet Dinner RIPA Annual Installation and Awards Banquet
ACPE: 0106-9999-15-037-L04-P
Friday Programming September 25, 2015
Upon completion of this activity, participants should be able to: 1. Discuss why metrics are utilized in pharmacies. 2. Identify the different types of metrics that are seen in community pharmacy practice. 3. Determine which metrics, if any, are most likely to impact patient safety. 4. Describe potential solutions to ensure patient safety in community pharmacies.
6:00 a.m. – 8:00 a.m. Check In & Registration/Exhibitor Set-Up 7:15 a.m. – 8:15 a.m. Continental Breakfast 8:00 a.m. Welcome 8:15 a.m. – 9:15 a.m. Interpersonal Education & Practice: Revolutionary Change ACPE: 0106-9999-15-048-L04-P
Presented by: Reid Blackwelder, MD, FAAFP and L. Brian Cross, PharmD, BCACP, CDE, The East Tennessee State University Family Physicians Clinic, Kingsport, TN Upon completion of this activity, participants should be able to: 1. Describe payer programs that incentivize health care professionals to improve patients’ outcomes (payment reform is happening). 2. Discuss effective strategies for incorporating pharmacists & technicians into health care teams. (delivery models are changing). 3. Describe roles and responsibilities of pharmacists & technicians in a team-based care setting. (true patientcentered models). 4. Explain how pharmacists bring value to the health care team and contribute to meeting patient outcomes as a part of community-based care. (triple/ quadruple aim of health care).
Presented by: Lauren S. Schlesselman, MA Ed Psych, PharmD, Assistant Dean, Academic & Strategic Initiatives, University of Connecticut School of Pharmacy
10:25 a.m. – 11:00 a.m. - Break 11:00 a.m. – 12:00 p.m. Oh my STARS! What Every Pharmacist Needs to Know ACPE: 0106-9999-15-038-L03-P
Presented by: Tara Higgins, PharmD, CDOE, Clinical Pharmacy Director, Rhode Island Primary Care Physician Corporation Upon completion of this activity, participants should be able to: 1. Explain what the Medicare 5-Star ratings are. 2. Describe the Medicare 5-Star ratings that are related to pharmacy and pharmacists. 3. Review how Medicare 5-Star ratings can be improved by pharmacy services. 4. Define the opportunity for pharmacists to benefit from Medicare 5-Star ratings in all healthcare settings. 12:00 p.m. – 2:00 p..m. Lunch and Exhibits
Schedule of Events Student Program 10:00 a.m. – 11:00 a.m. Interviewing Techniques Paul LaRochelle, Jr. Pharm.D. More programming TBD
12:30 p.m. – 1:00 p.m. Product Theater 2:00 p.m. – 3:00 p.m. Track 1: ADE Prevention Initiatives: Aligning to Reduce Patient Harm ACPE: 0106-9999-15-039-L05-P
Presented by: Patricia M. Noga, PhD, RN, Massachusetts Hospital Association Upon completion of this activity, participants should be able to: 1. Describe two opportunities for advancing ADE prevention strategies/ tools for inpatient or outpatient settings as identified by the HHS National Action Plan for ADE prevention. 2. Identify one national or statewide initiative implemented to prevent adverse drug effects. 3. Cite one strategy that you can implement in your workplace environment to prevent ADEs. Track 2: The Resurrection of Immunotherapy in Oncology ACPE: 0106-9999-15-040-L01-P
Presented By: Nicholas Forcello, PharmD, BCPS, BCOP, Clinical Oncology Pharmacy Specialist, Hartford Hospital, Hartford, CT Upon completion of this activity, participants should be able to: 1. Discuss immune-modulation as an antineoplastic therapeutic modality. 2. Examine the efficacy and safety of the FDA-approved immune-modulating therapies. 3. Examine a sample of emerging
immune-modulation therapies. Track 3: What Did You Say? Current and Emerging Therapies in the Treatment of Alzheimer’s Disease ACPE: 0106-9999-15-041-L01-P
Presented by: Jared L. Ostroff, PharmD & Marissa L. Wolff, PharmD, BCPS, Western New England University, College of Pharmacy Upon completion of this activity, participants should be able to: 1. Identify the symptoms and disease progression of Alzheimer’s disease. 2. Summarize current guidelines and recommendations for Alzheimer’s care. 3. Compare and contrast key differences with medications currently available versus emerging therapies. 4. Demonstrate knowledge of several emerging therapy options for patients with Alzheimer’s disease. Track 4: New England College “Pepto Bowl” Students and Pharmacists SelfCare Championship ACPE: 0106-9999-15-042-L04-P
Moderator: Jeffrey Bratberg, PharmD, URI College of Pharmacy. Kingston, RI Upon completion of this activity, participants should be able to: 1. Identify products (and active ingredients) routinely used for safe and effective use in self-care conditions. 2. Explain the efficacy, dosage, adverse effects, and administration of nonprescription medicines. 3. Counsel on non-pharmacologic measures for the treatment of common self-care ailments. 3:05 p.m. – 4:05 p.m. Track 1: Adverse Drug Events in the Elderly: A Focus on Anticoagulants, Opiates and Hypoglycemic Agents ACPE: 0106-9999-15-043-L01-P
Upon completion of this activity, participants should be able to: 1. Discuss recent findings on medication use by the elderly with implications for emergency department visits and hospital admissions. 2. Compare and contrast the hypoglycemic risk for various antidiabetic medications and describe various clinical scenarios where patients are predisposed to adverse glycopenic events with these medications. 3. Review selected oral anticoagulants for recognized and emerging risk factors for drug-induced bleeding. 4. Identify risk factors for opioidinduced respiratory depression with an emphasis on prevention and monitoring strategies. Track 2: Improving the Care of Cancer Patients Receiving Oral Chemotherapy ACPE: 0106-9999-15-044-L01-P
Presented By: Maggie Charpentier, University of Rhode Island Upon completion of this activity, participants should be able to: 1. Identify the newer oral chemotherapy agents. 2. Recognize toxicities unique to oral chemotherapy. 3. Select strategies to support patients during their oral chemotherapy. 4. Implement the information learned to educate patients to enhance their adherence to oral chemotherapy.
You may attend any track. You do not have to stay in the same room for all 4 sessions.
Presented by: Dennis J Chapron, RPh, MS Medication Safety Pharmacist, Saint Francis Hospital and Medical Center, Hartford, CT
17
4:20 p.m. – 5:20 p.m. Track 1: Transitions of Care: Pharmacists’ Role: Referral System and Interventions
Track 3: The Role of Pharmacists in Improving Medication Management in Mental Health
Presented by: Sarah Thompson, PharmD, Director of Clinical Pharmacy Services and Quality at Coastal Medical, Inc., Providence, RI
Presented by: Douglas Boggs, PharmD, MS, BCPP, Clinical Pharmacy SpecialistOutpatient Psychiatry, VA CT Healthcare System, Associate Research Scientist, Yale School of Medicine, Department of Psychiatry, New Haven, CT; and Angela A. Boggs, PharmD, BCPP, Clincial Pharmacy SpecialistOutpatient Psychiatry, VA CT Healthcare System
ACPE: TBD
Track 3: Update on the Treatment of Generalized Anxiety Disorder and Panic Disorder: A Focus on the Role of Benzodiazepines ACPE: 0106-9999-15-044-L01-P
Presented By: Michael Angelini, PharmD, MCPHS University Upon completion of this activity, participants should be able to: 1. List the signs and symptoms of GAD and PD. 2. Describe the standard guideline recommendations for acute and maintenance therapy for GAD and PD. 3. Demonstrate the role of benzodiazepines in the treatment of GAD and PD. 4. Develop a plan to enhance appropriate evidence-based pharmacotherapy for the treatment of GAD and PD. 4:05 p.m. – 4:20 p.m. - Break
Objectives: TBD Track 2: New Oral Chemotherapies: Mechanisms, Monitoring, and Management ACPE: 0106-9999-15-045-L01-P
Presented by: Britny Rogala, PharmD, Oncology Pharmacist Clinician, University of Vermont Medical Center, Burlington, VT Upon completion of this activity, participants should be able to: 1. Define the role and pharmacology of newly approved oral targeted therapies. 2. Review pertinent adverse effects, drug interactions, and administration and drug handling concerns. 3. Describe how to monitor for and manage common toxicities.
ACPE: 0106-9999-15-046-L01-P
Upon completion of this activity, participants should be able to: 1. Explain the barriers to delivering effective long-term treatments to people with mental health disorders. 2. Discuss the reasons patients report they stop taking medications. 3. Recognize the difference between a therapeutic medication regimen and polypharmacy. 4. Identify therapeutic strategies that can be implemented to increase medication adherence. Adjourn
NEW Pharmacy-Based Cardiovascular Disease Risk Management Certificate Program This practice-based activity is the first step for pharmacists interested in learning the essential skills to successfully assess risk, promote cardiovascular disease prevention, and encourage patient adherence to therapy.
18
September 24, 2015 8:00 a.m. to 5:00 p.m. • A discussion regarding the role of the pharmacist and existing business models for cardiovascular disease risk management services.
The activity is conducted in two parts: a web-based self-study and a live training seminar. The live seminar will focus on these core areas:
Faculty: Meghan Wilkosz, PharmD, Clinical Pharmacy Specialist – Acute Medicine, VA Connecticut Healthcare System West Haven, CT, Susan Holden, PharmD, Clinical Pharmacist VA Boston Healthcare System, West Roxbury, MA
• A case-based approach to cardiovascular disease risk assessment and treatment decisions, managing special situations, treating hypertension in a patient with diabetes, and lifestyle modifications and motivational interviewing. • Skills assessments on blood pressure measurement technique and motivational interviewing. Participants will be conducting blood pressure assessments on other participants.
The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of CPE. The self-study learning component of the APhA Pharmacy-Based Cardiovascular Disease Risk Management certificate training program is approved for 12 hours (1.2 CEUs) of continuing pharmacy education credit (UAN 0202-0000-15-001-H04-P; 0202-9999-15-001-H04-P). The live training seminar is approved for 8 hours (0.8 CEUs) of
continuing pharmacy education credit (UAN 0202-0000-15-002-L04-P; 0202-9999-15-002-L04-P). A Certificate of Achievement is awarded to participants who successfully complete all activity requirements, which include the self-study component, live training seminar, and the injection technique assessment. Successful completion is defined as a score of 70% or better on both the self-study and live seminar assessments. Pharmacy-Based Cardiovascular Disease Risk Management is developed by the American Pharmacists Association.
Registration Information Online Registration
Please go to www.nepharmacists.org to register. Deadline for online registration is September 16, 2015. Fax or Mail
Fax form with credit card information to 781-933-1109. Please make all checks payable to the New England Pharmacists Convention. Mail form to NE Convention, c/o MPhA., 500 W. Cummings Park, Suite 3475, Woburn, MA 01801.
Hotel Information
Please complete all portions of the registration form.
Four Points by Sheraton 1125 Boston Providence Turnpike (Route 1) Norwood, MA 02062 The special room rate is $140 per night for a standard queen. To make a reservation call (781) 769-7900 or e-mail lucy.finnerty@hobbsbrook.com OR Best Western Plus: the Inn at Sharon/Foxoborough 395 Old Post Road (Route 1) Sharon, MA 02067 For reservations, call (781) 784-1000 or visit book.bestwestern.com
OR Hampton Inn Franklin/Milford 735 Union Street Franklin, Massachusetts 02038
If you register after September 16, there will be an additional $10 fee. Registration Questions
Please contact MPhA at 781-933-1107 or at info@masspharmacists.org Cancellations must be made in writing to MPhA. Registration cancellations received prior to 8/30/15 will be refunded less a $25 processing charge per registrant. Cancellations received after 8/30/15 will not be refunded.
Tel: (508) 520-2999 Rates are $119/night for one room, king, non-smoking. Book by August 24th to get this rate.
Continuing Education Information: In order to receive a statement of credit uploaded to CPE Monitor, participants must complete an evaluation and CE registration form, in addition to
Continuing Education Credits The Connecticut Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Attendees can earn up to 11.5 hours (1.15 CEUs) of continuing education credit which includes 2 hours (0.2 CEUs) in pharmacy law.
19
To Register Online, please visit www.nepharmacists.org
Registration Form
Bundled CE Options
Convention Registration Rates
Member rates apply for members of CPA, MPhA (MA), NHPA, NEW! Pharmacy-Based Cardiovascular Disease Risk Management & RIPA, VTPA, and MPARX. Friday CE** Member $430.00 Non-Member $525.00 Full Convention*
(includes CE, Reception, Friday breakfast, lunch & exhibit hall) Member $189.00
Delivering Medication Therapy Management Services & Friday CE**
Member $430.00
Non- Member $239.00
The Pharmacist and Patient-Centered Diabetes Care & Friday CE* *
Member $430.00
Thursday Only*
(includes CE and Reception) Member $119.00
Non-Member $525.00 Non- Member $525.00
Deadlines for all Certificate program registration is August 31, 2015. All Bundle CE options include Friday CE offerings, breakfast, lunch, and Exhibit Hall.
Non- Member $130.00
**do not include reception or banquet
Friday Only*
(includes CE, breakfast, lunch & exhibit hall) Member $149.00
Non-Member $189.00
Member $379.00
Non- Member $429.00
Additional Offerings
Installation & Awards Banquet (includes Foundation cocktail reception with one free drink ticket) Student: $50.00 *Does not include Certificate Programs or Banquet Select Banquet: CPA $65.00 per person #___________ MPhA $70.00 per person #_________ Certificate Programs RIPA $120.00/couple #__________ $65.00/person________ NEW! Pharmacy-Based Cardiovascular Disease Risk Management Guest Friday Lunch & Exhibit Hall (does not include CE offerings) Member $379.00 Non- Member $429.00 $35.00 per person #_____ Delivering Medication Therapy Management Services Guest Name___________________________________
Tickets to Ed Sheeran Concert Gillette Stadium, September 25, 2015 Featuring Christina Perri and Passenger
The Pharmacist and Patient-Centered Diabetes Care
Member $379.00
Non-Member $429.00
Club Seats $95.00/ticket ______ (tickets will be mailed)
All Certificate Programs include breakfast, lunch and a break
***For all programs, please cite Source Code 10030 when registering online or via phone.
Total Amount: $
Name: ______________________________________________________________________________________ Prefix
First
Middle Initial
Last
Street Address: __________________________________________________________________________ City: __________________________________________State: _______ Zip: _____________ Telephone: _____________________________________Email: _______________________________________ State Association & Member Number: ____________________________________________________________ Practice Setting_______________________________________________________________________________ Optional
Students Only: University/College___________________________________________________Year of Grad.______________ Currently Enrolled
Payment Method: Credit Card:
MC
VISA
AMEX
Check
(payable to New England Pharmacists Convention)
Credit Card #:___________________________Security Code#: ________ Expiration Date: ______________ Card Holders Name:__________________________________________________________________________ Signature:____________________________________________________ Date: __________________________ 20
Certificate Programs
®
The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Pharmacist & Patient-Centered Diabetes Care Certificate Training Program September 24, 2015 8:00 a.m. to 5:00 p.m. The Pharmacist and Patient-Centered Diabetes Care Certificate Training Program is an intensive educational experience designed to equip pharmacists with the knowledge, skills, and confidence needed to provide effective, evidence-based diabetes care. Five self-study modules provide comprehensive instruction in current diabetes concepts and standards of care. The live seminar incorporates case studies and hands-on skills training focused on the situations most likely to be encountered—as well as the services most needed—in community and ambulatory care practice settings. Participants will gain experience evaluating and adjusting drug therapy regimens for patients with type 1 and type 2 diabetes, counseling patients about lifestyle interventions, analyzing and interpreting self-monitoring of blood glucose results, and assessing the overall health status of patients to identify needed monitoring and interventions. The goals of the certificate training program are to: • Provide comprehensive instruction in current standards of care for patients with diabetes. • Increase pharmacists’ confidence in serving as the drug therapy expert on the diabetes health care team. • Refresh pharmacists’ knowledge of the pathophysiology of diabetes and the acute and long‐ term complications of the disease.
• Familiarize pharmacists with important concepts in nutrition, exercise, and weight control that contribute to optimal diabetes care. • Provide training on the use of diabetes-related devices and physical assessments involved with optimal diabetes care. • Describe business opportunites and roles for pharmacists in improving health outcomes for patients with diabetes. This entire certificate training program will offer you the opportunity to earn up to 23 hours (2.3 CEUs) of continuing pharmacy education credit. SEMINAR AGENDA: Welcome & Introduction Comprehensive Care Needs Intensifying Drug Therapy Nutrition Counseling Insulin Therapy Hands-On Assessments Special Situations in Diabetes Management Next Steps and Resources Closing Remarks
This practice-based activity teaches pharmacists the essential skills necessary to become a successful MTM practitioner. The certificate training program will enhance pharmacists’ clinical expertise in evaluating complicated medication regimens, identifying medication-related problems, and making recommendations to patients, caregivers, and health care professionals. The certificate training program is conducted in three parts: a self-study activity and pre-seminar exercise, a live interactive training seminar, and a post-seminar exercise. The goals of the certificate training program are to: • Advance public health and patient care through improved medication use. • Provide training to enhance pharmacists’ ability to effectively provide MTM services.
Successful completion of the self-study component involves passing the self-study assessment with a grade of 70% or higher and will result in 15.0 contact hours of continuing pharmacy education credits (1.5 CEUs) ACPE UAN: 0202-9999-14-166-L04-P; 0202-9999-14-166-L04-P The Pharmacist & Patient-Centered Diabetes Care was developed by the American Pharmacists Association.
Faculty: Kristen Rychalsky, Pharm D., BCPS Clinical Pharmacy Specialist
Delivering Medication Therapy Management Services Delivering Medication Therapy Management Services is an innovative and interactive certificate training program that explores the pharmacist’s role in providing MTM services to patients. Pharmacists have a tremendous opportunity to receive reimbursement for monitoring and improving medication use in patients with complex medication regimens.
CONTINUING PHARMACY EDUCATION (CPE) CREDIT: RELEASE DATE : 2/1/2012 Successful completion of the live seminar component involves passing the final exam with a grade of 70% or higher and demonstrating competency in blood pressure testing, selfinjection techniques, diabetic foot exam, and blood glucose testing. Successful completion of these components will result in 8 contact hours of continuing pharmacy education (0.8 CEUs) ACPE UAN: 202-999-12-107-L04-P
September 24, 2015
• Motivate increased numbers of pharmacists to establish MTM services. • Communicate benchmark practices for providing MTM services. SEMINAR AGENDA: The Patient Interview Pre-Seminar Case Review: Communication Barriers Case Study: William Documentation The Medication Therapy Review Case Study: Carl Setting Therapeutic Goals Medication-Related Action Plan Standardized Case Review: Toni Recommendation to Other HealthCare Professionals Cultural Sensitivity The Senior Patient Case Study: Donna Staying Current Standardized Case Review: Toni Implementation SWOT Analysis Setting Business Goals and Recruiting Patients Billing Concepts, CPT Coding, and Measuring Outcomes Take Home Points and Post-Seminar Assignment Patient Case Assessment Discussion
8:00 a.m. to 5:00 p.m.
Evaluation and Adjourn This entire certificate training program will offer you the opportunity to earn up to 21 hours (2.1 CEUs) of ACPE-accredited continuing pharmacy education credit. Faculty: Alexandria Dunleavy, Pharm.D., Staff Pharmacist, Walmart Pharmacy, Worcester, MA Successful completion of the self-study component will result in 10 contact hours of continuing pharmacy education credit (1.0 CEUs). ACPE UAN: 0202-0000-14-H04-P; 0202-9999-14-158-H04-P Successful completion of the live seminar component will result in 8 contact hours (0.8 CEUS) of continuing pharmacy education credit (0.8 CEUs). ACPE UAN: 0202-0000-14-159-L04-P; 0202-9999-14-159-L04-P Successful completion of the post-seminar exercise will result in 3.0 contact hours of continuing pharmacy education credit (0.3 CEUs). ACPE UAN: 0202-0000-14-159-L04-P; 0202-9999-14-160-H04-P
21
Feature Vaccine Therapy Strides Forward by Karl Granskog, PharmD and Jennifer Girotto, PharmD Over the past 12 months there have been many new recommendations and new vaccines. The Advisory Committee on Immunization Practices (ACIP) has provided updated recommendations for influenza, pneumococcal, and zoster vaccines, while newly FDA approved human papillomavirus virus vaccine and two meningococcal serogroup B vaccines have recommendations published.
Influenza For 2015, the ACIP voted to continue to recommend that all persons 6 months and older be vaccinated annually against influenza. Interestingly, they did not renew their 2014-2015 recommendation that healthy children 2 through 8 years preferentially receive the live attenuated influenza vaccine (LAIV), rather than inactivated influenza vaccine (IIV). This change was due to data demonstrating no superiority between the two vaccines1. Further, in the 2013-2014 flu season, the LAIV demonstrated no efficacy against the circulating H1N1 virus likely due to storage conditions, while the IIV demonstrated a statistically significant 60% vaccine efficacy1. For the 2014-2015 flu season, both types of influenza vaccines performed poorly because of a mismatch between the vaccine composition and the circulating strains.1,2 For the upcoming 2015-2016 flu season, the composition of the 2015-2016 influenza vaccine will continue to contain the A/California /7/2009 (H1N1)pdm 09-like virus, but it will have a change in the second type A and the type B strains, with an A/Switzerland/9715293/2013 (H3N2)-like virus and a B/Phuket/3073/2013-like virus included in the trivalent vaccines. The quadrivalent vaccine will have the additional B/ Brisbane/60/2008-like virus which was included in last year’s quadrivalent as well.3
New Pneumococcal conjugate vaccine 13 (PCV13) Recommendation In August 2014, the ACIP recommended that PCV13 be added to the routine recommendation for all patients 65 years old and older who have not previously received a dose.4 This recommen22
dation is in addition to the prior recommendation that these patients receive a dose of PPSV23. This change followed the results of the Community Acquired Pneumonia Immunization Trial in Adults (CAPiTA) trial4. In those 65 years and older who have not previously received pneumococcal vaccine or whose previous vaccination history is unknown, the PCV13 dose should be given first, followed by the PPSV23 dose, about 6-12 months later. The minimal acceptable interval between PCV13 dosing followed by PPSV23 dosing is 8 weeks and this spacing is what is recommended for the highest risk (e.g. immunocompromised, asplenia) patients of all ages. Those at least 65 years old who have received prior doses of PPSV23, should still receive a dose of PCV13. This dose of PCV13 should be given not sooner than 1 year after the most recent PPSV23 dose. If an additional dose of PPSV23 is indicated, this should be administered 6-12 months after the PCV13 dose and 5 years after a prior PPSV23 dose.4
Herpes Zoster Vaccine In 2014, the Advisory Committee on Immunization Practices (ACIP) voted to not recommend the zoster vaccine in patients less than 60 years old5. Their recommendation was based upon a cost-benefit review and long-term efficacy evaluation of the vaccine. Since the zoster vaccine’s efficacy begins to wane to an undetermined level after 5 years6, 7, the ACIP recommendation times optimal immunogenicity with patient ages having the greatest probability of herpes zoster and post herpetic neuralgia. New Human Papillomavirus (9vHPV) Vaccine A new, expanded nine-valent HPV vaccine, Gardasil 9 (9vHPV, Merck), was recently approved for females 9 through 26 years of age and males 9 through 15 years of age8. It is indicated for the prevention of cervical, vulvar, vaginal (females) and anal dysplastic and precancerous lesions caused by HPV types 6, 11, 16, 18,
Pharmacy Journal of New England • Summer 2015
31, 33, 45, 52, and 58; the prevention of cervical, vulvar, vaginal (females) and anal cancers caused by HPV types 16, 18, 31, 33, 45, 52 and 58; and the prevention of genital warts caused by HPV types 6 and 11. In March 2015, the ACIP published guidance broadening the recommendations to include 9vHPV as an alternative for all of the indications where 4vHPV was recommended.9 Specifically, the 9vHPV is an option for routine vaccination generally beginning at age 11-12 years. Additionally, it can be used for catch up in unvaccinated females 13-26 years, males 13-21 years, males through 26 years with a history of MSM, and certain immunocompromised individuals through age 26 if not previously vaccinated.9 It is important to note that
interference with the HPV type 18, but this did not affect the achievement of seroconversion after completion of the vaccination series for this strain.12
the ACIP did not provide a preference for one HPV vaccine over another in situations where more than one was recommended. Furthermore, the ACIP stated that patients who had begun their vaccination with either 2vHPV or 4vHPV can complete their 3dose series with the 9vHPV.9 The administration of 9vHPV is similar to other HPV vaccines: it is a 3 dose series (0, 2 and 6 months) given as a 0.5mL intramuscular dose in the deltoid muscle or higher anterolateral area of the thigh at 0, 2, and 6 months.8 The syringes are available in 10-pack cartons, while the vials are available in single or 10-pack cartons. 9vHPV should be stored in a refrigerator (36°F-46°F), but may be kept outside of the refrigerator (≤ 77°F) for 72 cumulative hours.
Further on June 24, 2015 the ACIP voted (and will only become recommendation after it is published in the MMWR) on a permissive recommendation, which would provide healthcare providers the option of routine vaccination of healthy individuals 16–23 years olds, with the optimal timing if used being between 16 and 18 years.13 The optimal timing of 16 through 18 years was chosen because the vaccine is known to be effective for at least 2 years but duration after that time point has yet to be established.13
New Meningococcal Group B (MenB) Vaccines There are 2 new meningococcal vaccines, Bexsero10 (MenB-4C, Novartis Vaccines) and Trumenba11 (MenB-FHbp, Pfizer-Wyeth), both of which were recently FDA approved to prevent Neisseria meningitidis serotype B in adolescents. These vaccines are different than the currently available meningococcal vaccines. Previous meningococcal vaccines have covered a combination of N. meningitidis serotypes including A, C, Y, and W135. These new vaccines have both been FDA approved for active immunization to prevent invasive disease caused by N. meningitidis serotype B in 10-25 year olds. Both vaccines have common sideeffects expected of an inactivated vaccine including commonly local reactions, headache, and fatigue.12 MenB-4C has not been studied with other adolescent vaccines, but MenB-FHbp when studied in adolescents did not demonstrate any immunologic interference with MenACWY, tetanus, diphtheria, pertussis, IPV or HPV strains 6, 11, or 16. Additionally, there was some potential
On June 12, 2015 ACIP published recommendations for the routine use of these MenB vaccines in high risk patient’s 10 years of age and older.12 Specifically for patients with persistent complement deficiencies (including those with deficiencies in C3, C5-9, properdin, factor D, or factor H, and those receiving eclulizumab), functional or anatomic asplenia, microbiologists who routinely work with N. meningitides, or those identified as high risk due to a meningococcal serogroup B outbreak.12
MenB-4C is administered as a two dose series separated by 1 month, while the MenB-FHbp is a 3 dose series given at 0, 2 and 6 months.10,11 Both N. meningitidis serotype B vaccines are administered as 0.5 mL intramuscular injection. They are not substitutable as they are different in their compositions and schedules. From an allergy perspective the MenB-4C contains trace amounts of kanamycin and its syringe tip cap contains latex.10 Both vaccines are stored in the refrigerator and come as pre-filled single dose syringes. MenB-4C is available in individual or 10-syringe packs, while MenB-FHbp is available in 5 or 10-syringe packs.10,11 References 1. CDC Newsroom Media Statement: Advisory Committee on Immunization Practices (ACIP) reaffirms recommendation for annual influenza vaccination. Centers for Disease Control and Prevention (CDC) website. http://www.cdc.gov/media/releases/2015/s0226acip.html Published February 26th, 2015. Accessed March 30th, 2015. 2. Influenza Update. Bulletin #235. http://www.who.int/influenza/surveillance_monitoring/ latest_update_GIP_surveillance/en/ Published April 20th, 2015. Accessed April 28th, 2015. 3. Influenza. Recommended composition of influenza virus vaccines for use in the 20152016 northern hemisphere. http://www.who.int/influenza/vaccines/virus/recommendations/2015_16_north/en/ Published February 26th, 2015. Accessed March 30th, 2015. 4. Centers for Disease Control and Prevention (CDC) Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2014; 63(37):822-825.
(References continue on page 36) 23
Pharmacy Marketing Group
Rx and the Law By: Don R. McGuire Jr., R.Ph, JD This series, Pharmacy and the Law, is presented by Pharmacists Mutual Insurance Company and your State Pharmacy Association through Pharmacy Marketing Group, Inc., a company dedicated to providing quality products and services to the pharmacy community.
Wrongful Conduct Rule A recent decision in West Virginia is garnering a lot of attention in the pharmacy profession and beyond. The eight cases involve suits by 29 patients alleging that actions by physicians and pharmacists have caused them to become addicted to and abuse controlled substances. They also alleged that the pharmacies acted in concert with the prescribers by such actions as refilling prescriptions early and filling contraindicated prescriptions. After some years of prescribing by the 4 physicians involved, and dispensing by the 3 pharmacies involved, an FBI raid resulted in arrests of some of the health professionals. Some physician licenses were revoked and some were convicted and served prison time. However, only 1 pharmacy and 1 pharmacist were disciplined (the court decision does not indicate that there were any criminal charges). As the cases progressed, the plaintiffs all admitted to various crimes during the time that they were receiving and filling prescriptions for the various controlled substances. These included criminal distribution, buying drugs off the street in
24
addition to those prescribed, acquiring prescriptions through misrepresentation, fraud or forgery, and doctor shopping. Because of these criminal activities, some of the defendants filed a motion to have the case dismissed on the basis of the Wrongful Conduct rule or the in pari delicto (in equal fault) doctrine. These two concepts have similar origins, but in pari delicto is used more commonly in contractual or transactional disputes. The premise of the Wrongful Conduct rule is that someone who is injured while performing an immoral or criminal act should not be able to recover damages for that injury. The Court quoted another case to explain the rationale for the rule; “. . . public policy that courts should not lend their aid to a plaintiff who founded his cause of action on his own illegal conduct.” The trial court agreed to dismiss the cases, but then sent certified questions to the Supreme Court of Appeals.
The Supreme Court of Appeals declined to invoke the Wrongful Conduct rule in West Virginia because the majority believed the rule was too ambiguous and difficult to apply. They ruled that the jury would take the criminal activity into account when apportioning fault under West Virginia’s comparative fault laws. In West Virginia, if the plaintiff is 50% or more at fault, then they cannot recover any damages. The Court said that comparative fault will essentially take the wrongful conduct of the plaintiff into account, so the Wrongful Conduct rule is unnecessary. There were 2 dissenting opinions that disagreed with the majority that the rule would be difficult to apply. The dissenting opinions said that it is straightforward; a person should not be able to recover for injuries sustained while committing a crime. Thirteen other states have already adopted the rule. By not invoking the rule, the Court will encourage other criminals to file suits to attempt to profit from their criminal activity. In these particular cases, they contend that the Court is allowing these plaintiffs to clog up the court docket and waste the court’s time. What does this mean for pharmacists? It’s important to recognize that there has been no trial and no judgment on the facts of these cases. The decision does not mean that the pharmacists or physicians are liable. This opinion is a procedural one that places the eventual resolution of the case in the jury’s hands instead of the judge’s hands. Many readers have probably already formed an opinion about the correctness of the decision. For pharmacists, the real issue is to try not to get involved in such a case in the first place. While this is not always possible, it should be a goal. The monitoring and dispensing of controlled substances is difficult at best. Pharmacists are no longer “order takers” subservient entirely to the doctor’s orders. Pharmacists should be active and diligent in monitoring all of their patients, but especially those with unusual controlled substance needs. Pharmacists need to educate themselves about their patients’ needs. There are plenty of reference articles about effective pain management to consult. Pharmacists also need to educate themselves about their responsibilities as health care professionals. The tightrope between patient needs and good stewardship of controlled substances is not easy to navigate, but ignoring the issue is not a solution.
From the Colleges
Pharmacy Journal of New England • Summer 2015
University of Connecticut School of Pharmacy School Celebrates a Major Milestone The 2015-2016 academic year marks the 90th Anniversary of the UConn School of Pharmacy. The school originally opened its doors on October 20, 1925 in New Haven, as the Connecticut College of Pharmacy before joining with the state’s flagship university in 1941. It was due to the efforts of a professional organization – the Connecticut Pharmaceutical Association – that the school was originally established. Pharmacy professionals in the state believed it was their duty to provide training in the profession and they worked toward the goal of a formal school in the state. Both the profession and the school have come a long way since that day, evolving with the changing needs of the healthcare landscape. UConn is the number one pharmacy school in New England, and in the top 20 percent of schools nationwide, and generations of Connecticut pharmacists have trained here. In celebration of our 90 years, the school will be profiling a small sampling of our alumni over the coming year. It is truly our people who have made this school great, and it is those with an UConn pharmacy degree who have helped shape the profession in this state for the last 90 years. Here are a few examples of those who have served the profession, the University of Connecticut, or the State of Connecticut over the years. Richard T. Carbray, Jr. ’75, began his career in community pharmacy working at McNeil’s Pharmacy in Cromwell and Ferndale Drug in Kensington. He spent two years as a professional sales representative for Schering Laboratories before returning to community pharmacy as vicepresident of Pelton’s Pharmacy and Home Health Center in Middletown. He owned and operated Apex Pharmacy and Home Health Center in Hamden and recently sold the business. Carbray is active in professional and public affairs. His
involvement in the community is extensive, serving on the Newington Town Council since 1997 and as its majority leader since 2001. He is a past member of the Wethersfield Chamber of Commerce Board of Directors, the Wethersfield Visiting Nurses Association, the Middletown Visiting Nurses DUR Committee and several other organizations. Among the awards he has received are Irish Person of the Year, A. H. Robins Bowl of Hygeia for community service and Connecticut Pharmacists Association Pharmacist of the Year. He is a past president of the Pharmacy Alumni Association and the Connecticut Pharmacists Association, as well as past president of the UConn Alumni Association. Carbray currently serves on the Connecticut Pharmacy Commission and the UConn Board of Trustees. Margherita Giuliano ’75, worked briefly for a chain pharmacy and then opened her own community pharmacy where she practiced for 17 years. After selling her business, Giuliano served as the board administrator for the State of Connecticut Commission of Pharmacy. There she was involved in the rewriting of pharmacy state regulations and the legislative process. She also served on the National Association of Boards of Pharmacy’s Multistate Pharmacy Jurisprudence Exam Review Committee. Since June of 1999, Giuliano has been executive vice president of the Connecticut Pharmacists Association. She is a seasoned leader in the pharmacy community having served as president of the state association in 1997-98 and as past president for the National Alliance of State Pharmacy Associations in 2009. Giuliano served on the national advisory panel of pharmacy leaders that developed Medication Therapy Management in Pharmacy Practice: Core Elements of an MTM Service Model Version 2.0 She has served on various state and national
25
From the Colleges
continued
health task forces and has participated in demonstration and research projects involving women’s heart disease, smoking cessation initiatives and most recently projects in Medication Therapy Management, one of which won an APhA Pinnacle Award. Marghie has also presented many lectures to the pharmacy community on legislative and legal issues, and serves as a preceptor at the UConn School of Pharmacy. She currently sits on the Board of Directors for eHealth Connecticut and the CT Partners for Health. Edmund E. Goodmaster, Sr. ’33 served as a pharmacist mate in World War II and earned four ribbons and two bronze stars. Eddie took a position in community pharmacy and, in 1946, joined the Connecticut Pharmacy Commission as an inspector. After 19 years as chief inspector, he was appointed executive secretary of the commission. Shortly after his retirement, Governor William O’Neill appointed him to the Connecticut State Board of Examiners for nursing. He passed away at the age of 71 on December 10, 1984. Samuel S. Kalmanowitz ’61, was entrepreneurial from the outset. He began his 40-year career as a Connecticut community pharmacist by establishing his own business, Kaye’s Pharmacy, in 1963. In 1990 he received the esteemed Bowl of Hygeia Award from A.H. Robins (now Wyeth) and was inducted into the Bowl of Hygeia Hall of Fame. In 1998 he was named Independent Superstar by the national publication Drug Topics, and Kaye’s Pharmacy was selected as the top independent pharmacy in the United States in 1998. He was named a distinguished alumnus by the Pharmacy Alumni Association and he received the 26
Connecticut Pharmacists Association’s Elan Pharmaceutical Award in Recognition of Innovative Pharmacy Practice. In addition to his contributions to the profession, Kalmanowitz was an active leader in his community, serving as chair of the Meriden Redevelopment Agency from 1988 to 1995. He led a project that redeveloped Meriden’s downtown area and also served on the building committee for the town’s new YMCA building. His civic contributions were recognized in 1997 when he was inducted into the Meriden Hall of Fame. Kalmanowitz joined an elite group as he was honored with the University of Connecticut Medal for his contributions to his community, to the profession of pharmacy, and to the University of Connecticut. This was the first time that a member of the School of Pharmacy received the university’s highest honor. Sam passed away on May 20, 2008, just days after receiving this honor. Kenneth Lalime ’79, has over 35 years of experience in the health care arena. Ken is the past executive director of the Connecticut State Medical Society-IPA, a 7,000-physician member independent practice association. Prior, he served as the chief operating officer at The Physicians Corporation; and he held numerous management positions throughout a 17-year tenure at Norwalk Hospital. Lalime was also co-owner of Cranbury Pharmacy in Norwalk from 1985 – 1995 and is a member of the Norwalk Board of Health since 1994. Ken’s passion for the development of an integrated model of care led him to the position of chief executive officer at HealthyCT (the Connecticut based CO-OP Health Insurance Company). With a background in hospital services (pharmacy, information technology, finance and administration), retail pharmacy, physician practice management and partnering with the health insurance industry, Ken brought a unique set of skills to the job. His vision is to craft a system built on coordination of care through the involvement of key contributors so Connecticut citizens will benefit from these efforts and the health literacy of the population will be enhanced. This will
Pharmacy Journal of New England • Spring 2015
Daniel C. Leone, Jr. ’51, retired after nearly 15 years as executive secretary of the UConn Pharmacy Alumni Association and director of alumni relations at the School of Pharmacy. This was his third retirement serving the profession. Leone graduated from the UConn School of Pharmacy in 1953, starting school when the campus was in New Haven, and finishing his degree in Storrs. In addition to his pharmacy studies, he was a brother of the pharmaceutical fraternity Kappa Psi and a member of the Mortar & Pestle Society. After graduation, Leone served in the military for two years at the Army Medical Service School in Texas. After his discharge, he went to work at the family business, Leone’s Pharmacy in Norwich, where he spent the next 20 years - first as a pharmacist, and then as partner and manager. When he sold the business in 1975, Leone became the executive vice president of the Connecticut Pharmacists Association, where he devoted the next 20 years. He retired again but, within the next year, became director of alumni relations at the School of Pharmacy where he spent the next 14 years. During his career, Mr. Leone received numerous awards including the Distinguished Pharmacy Alumnus, Distinguished University of Connecticut Alumnus and the A. H. Robbins Bowl of Hygeia Award. He also served on the University of Connecticut’s Board of Trustees, the first School of Pharmacy alumnus to hold this prestigious position.
regulatory requirements including, but not limited to: HIPAA Privacy and Security; Stark and the anti-kickback statute; controlled substances laws; drug quality and safety laws; accreditation, licensure and scope of practice; medical staff bylaws; medical records and health informa tion management; the Emergency Medical Treatment and Labor Act; and Hospital Conditions of Participation and Joint Commission standards. Osowiecki is admitted to practice law in: the State courts of Connecticut and Massachusetts; the United States District Court for the District of Connecticut; the United States Courts of Appeals for the Second and Eleventh Circuits; and the Supreme Court of the United States. She is also a licensed pharmacist in the State of Connecticut. Osowiecki is also a frequent lecturer on various legal matters relating to healthcare, including healthcare reform, pharmacy laws, pharmaceutical waste regulation, medication errors and adverse events, confidentiality and privacy of medical information, and risk management. She is a member of the American Health Lawyers Association, the American Society for Pharmacy Law, the American Bar Association, and the Connecticut Bar Association. She is also a member of the Connecticut Pharmacists Association and a past president of the University of Connecticut School of Pharmacy Alumni Association Board of Directors. She is currently chair of the School of Pharmacy Advisory Board. These are just a small sample of those alumni who make an impact in our communities on a daily basis. Throughout the coming year, we look forward to sharing more about our history and our future.
Jennifer A. Osowiecki ’85, ’94 is a corporate healthcare attorney who provides legal advice to all levels of healthcare providers, including hospitals, specialty and general physician practices, pharmacies, individual practitioners, trade associations, and others serving the healthcare industry. Her practice focuses on business transactions, contracts, and compliance with statutory and 27
From the Colleges
continued
Massachusetts College of Pharmacy and Health Sciences – Boston
Science (HiTS) where he carried out research in genomics and managed projects in Regulatory Science, including work on drug toxicity funded by the FDA.
Dear Colleagues, On behalf of President Charles F. Monahan Jr. and Provost Douglas Pisano I bring you greetings from MCPHS University and hope that the summer finds you well. We have just had another successful year in the School of Pharmacy Boston and I would like to share the following highlights with you. Best Wishes, Paul DiFrancesco, EdD, MPA, RPh. Dean, MCPHS University, School of Pharmacy Boston
New Faculty Dr. Phung On recently joined the department of pharmacy practice as an assistant professor. Phung’s practice is that of a Transitions of Care pharmacist at Lahey Hospital & Medical Center in Burlington. She received her PharmD from MCPHS University, and she completed an ASHP accredited PGY1 pharmacy practice residency offered jointly by UNC Eshelman School of Pharmacy and Community Care of North Carolina. Prior to joining the MCPHS University faculty, Phung was with Comprehensive Pharmacy Services where she served as a clinical pharmacist at Lemuel Shattuck Hospital. She has received APhA certifications in immunization delivery, medication therapy management and patient-centered diabetes care. Dustin Holloway, PhD has taken on the role of Assistant Professor and Director of Biomedical Informatics at MCPHS University from a previous position at Harvard Medical School. At Harvard, Dustin served as Program Manager in the Harvard Program in Therapeutic 28
Dustin has a long experience in bioinformatics and genomics, having worked as a bioinformatics engineer at the Dana Farber Cancer Institute (DFCI) and previously as a Senior Scientist at Life Technologies where he participated in the team, headed by the Max Planck Institute, that sequenced and analyzed the first European genome sequence. Appreciating that the coming era of Big Data healthcare will have many ethical and legal dimensions, Dustin completed the Medical Ethics Fellowship at Harvard Medical School and served on the hospital Ethics Advisory Committee at Dana Farber. He also completed a Non-Stipendiary Fellowship in the Program on Science, Technology and Society at the Harvard Kennedy School of Government, and remains an Affiliate of the Personal Genetics Education Project. Dustin holds a Ph.D. in Molecular Biology, Cell Biology, and Biochemistry (MCBB) from Boston University where he attended as a Dean’s Fellow, and a B.S. in Microbiology from Penn State, where he was a Schreyer Scholar and a McNair Scholar.
Faculty Promotions Dr. Mary Amato, who maintains a practice at Brigham and Women’s Hospital, was promoted to Professor of Pharmacy Practice, Dr Larry Gracz, who teaches Biochemistry, to Associate Professor of Pharmaceutical Science, and Dr Kristin Zimmerman, who maintains a practice at the Brocton VA, to Associate Professor of Pharmacy Practice.
Student Achievements The MCPHS University Boston Psi Chapter of the Rho Chi Academic Honor Society in Pharmacy held its Induction Ceremony on Saturday March 21st, 2015 at the Hyatt Regency in Cambridge, MA. The William E. Hassan Jr. Distinguished Rho Chi Memorial Lecturer was Joseph T. DiPiro, Dean of the Virginia Commonwealth University School of Pharmacy. A total of 61 PharmD students from the Class of 2017, 12 Postbaccalaureate students from the Class of 2015, and 2 Graduate
Pharmacy Journal of New England • Summer 2015
students were inducted. Faculty inductees included NicholasA. Campagna Jr, MBA and Alissa Segal, PharmD.
New Programs This past year, MCPHS funded its first Pharmacogenomic/ Biomedical Informatics Post graduate PharmD Fellowship. The Fellow collaborates with the Pharmacogenomics Clinic at Children’s Hospital in Boston and the Center for Biomedical Informatics (CBMI) at Harvard Medical School. Because genomics and Pharmacogenomics involve working with large data ets and evolving processes and procedures, biomedical informatics in integral to the success of the endeavor. Dr. Laura Chadwick, who received her PharmD form MCPHS Worcester, has become the first fellow in the program and is
working in the areas of Pharmacogenomics and Biomedical Informatics at Harvard Medical School and Children’s Hospital. There Dr Chadwick is working with researchers to better understand how children’s genetic make-up affects different drug therapies. In conjunction with this fellowship program the School of Pharmacy Boston is offering a four baccalaureate degree in the area of Biomedical Informatics. The program is designed to formalize biomedical informatics education to prepare students in the application of information technology to improve clinical science and patient care.
Massachusetts College of Pharmacy and Health Sciences – Worcester/Manchester Dear Colleagues, We successfully graduated another 271 potential pharmacists from the Worcester/ Manchester Doctor of Pharmacy Program on May 9 at Gillette Stadium. It was a joyous occasion for all involved as the weather was extremely cooperative. We are looking forward to working with our new colleagues from the New England School of Acupuncture and our new School of Occupational Therapy this fall. We are now looking forward to welcoming a new crop of students for a new academic year in the fall of 2015. I hope everyone had a productive and enjoyable summer. All the best, Michael J. Malloy, PharmD, Dean and Professor
Faculty Spotlight -- MCPHS University Board of Trustees’ Teaching Award Dr. Abir Kanaan, Associate Professor of Pharmacy Practice, received the 2015 Trustees’ Award for Teaching Excellence on May 9, 2015 during the MCPHS University Commencement at Gillette Stadium in Foxboro, MA. Each year, MCPHS University presents this award, the University’s highest teaching award, to one faculty member from the Boston campus, and one from the Worcester and Manchester campuses. Candidates for this award are nominated by their peers and students, and ultimately chosen by a panel of students and previous award recipients based on their teaching portfolio. Dr. Kanaan is a graduate of our accelerated Doctor of Pharmacy degree program. She joined the SOP-W/M faculty in 2005. She was promoted to associate professor in 2011. Dr. Kanaan is known for promoting an integrated approach to teaching using patient scenarios and Jeopardy-style questions to improve students’ application of the material and critical 29
From the Colleges
continued
thinking skills. One of her rotation students who nominated Dr. Kanaan for this award stated, “She is always there to lead and facilitate the discovery process and is committed to the student and their development.” Dr. Kanaan is highly involved with the mentoring of new faculty and cofounded the Pharmacy Academic and Leadership Support (PALS) Committee. Additionally, Dr. Kanaan was awarded the Faculty Senate’s Long-Term Service Award at the Full Faculty meeting on May 5..
Below: Valerie Coppenrath receiving the Preceptor of the Year Award from Pharmacy Practice Chair Paul Belliveau
Awards Dr. Valerie Coppenrath received the SOP-W/M Faculty Preceptor of the Year Award. Dr. Coppenrath offers an advanced ambulatory care rotation at the Edward M. Kennedy Community Health Center.
Dr. Kaelen Dunican received the SOP-W/M Department of Pharmacy Practice Academic of the Year Award, which recognizes a faculty member in the department for excellence in the areas of Teaching, Scholarship, and Service.
Above: Kaelen Dunican receiving award from Paul Belliveau
Dr. Chase Smith received the SOP-W/M Department of Pharmaceutical Sciences Academic of the Year Award which recognizes a faculty member in the department for excellence in the areas of Teaching, Scholarship, and Service.
Above: Chase Smith receiving award from Pharmacy Sciences Chair, Carolyn Friel.
30
Pharmacy Journal of New England • Summer 2015
SOP-W/M Faculty Garner MCPHS University Faculty Scholarship and Service Awards, and Faculty Scholarship Showcase Awards At the MCPHS University Faculty Meeting on May 5th, the annual Scholarship Awards and Service Awards were presented to faculty. The Scholarship Awards were given out to recognize faculty who have authored or coauthored scholarly works that were published in the previous year in a peer-reviewed journal, book, or other venues considered scholarly by the faculty’s discipline. The scholarly works were reviewed by external reviewers who have expertise in the award categories. Scholarship of Teaching Award – Carroll-Ann W. Goldsmith Goldsmith CW, Tran TT, Tran L. An educational program for underserved middle school students to encourage pursuit of pharmacy and other health science careers. AJPE. 2014; 78(9), article 167. Scholarship of Integration Award – Mimi Mukhergee and Valerie Coppenrath Mukherjee SM, Coppenrath VA, Dallinga BA. Pharmacologic management of types 1 and 2 diabetes mellitus and their complications in women of childbearing age. Pharmacotherapy. 2015; 35(2):158-174. Scholarship of Discovery – Mattia Migliore and Robert B. Campbell Migliore MM, Ortiz R, Dye S, Campbell RB, Amiji MM, Waszczak BL. Neurotrophic and neuroprotective efficacy of intranasal GDNF in a rat model of Parkinson’s disease. Neuroscience. 2014; 274:11-23.
Fifth Annual MCPHS University Faculty Scholarship Showcase The showcase is an annual exposition for all MCPHS University faculty and staff to celebrate their scholarly achievements and share ideas. Eighteen posters were presented by SOP-W/M faculty members. Several of them received awards: Award Category for Application - Monina R. Lahoz, Paula
Evans, and Irena Bond. Enhancing the health information literacy skills of older adults Award Category for Discovery – Terrick A. Andey. Lipid nanocarriers of a lipid-conjugated estrogenic derivative inhibit tumor growth and enhance cisplatin activity against triple-negative breast cancer: Pharmacokinetic and efficacy evaluation Award Category for Integration - Tammy L. Gravel, Amanda M. Morrill, Sheila Seed, and Karen S. Lamson. An interprofessional collaboration to enhance veteran care at MCPHS University Award Category for Teaching - Terrick A. Andey. Correlating participation in voluntary online assessments and exam score in pharmaceutical calculations
NanoWorcester Symposium The 1st Joint NanoWorcester – AVS New England Symposium was held at WPI on April 29 and attracted 70 attendees from New England Universities, industries and government laboratories. The goal of the symposium was to form a collaboration between Worcester academic institutions who are interested in nanoscience, nanotechnology, nanomedicine research, and industry. The event showcased 35 posters from graduate and undergraduate research, provided opportunities for professional networking, and a selected academic/industry career advisory panel discussion offered student attendees a forum to receive feedback and guidance with regards to academic and industry careers. The keynote speaker was Dr. Igor Sokolov, a Bernard M. Gordon Senior Faculty Fellow in the Department of Mechanical Engineering at Tufts University. His presentation was titled “Interacting with the Nanoworld using Atomic Force Microscopy”. Dr. Alice Gardner helped organize the symposium and one of our graduate students, Taha Alqahtani, was the recipient of best graduate poster award.
NH Students and Faculty Meet with US Congress Delegates Faculty and students from the MCPHS University 31
From the Colleges
continued
Manchester campus met with New Hampshire delegates of the U.S. Congress to advocate for the passage of the federal pharmacists’ provider status legislation this past April. Drs. Kristine Willett and Jennifer Towle (also board members of the New Hampshire Society of HealthSystem Pharmacists) and Dr. Cheryl Durand (New Hampshire Pharmacists Association Board member) along with PharmD candidates (2015) Elizabeth Lagasse, Katharine Jones, Peter Caikauskas, Regan Sevinsky and Lejla Kadic met with staff members of the offices of Senator Kelly Ayotte, Senator Jeanne Shaheen, and District 1 Representative Frank C. Guinta.
Publications Aungst TD. Using a hackathon for interprofessional health education opportunities. J Med Syst. 2015; 39(5):60. Aungst TD, Miranda AC, Serag-bolos ES. How mobile devices are changing pharmacy practice. Am J HealthSyst Pharm. 2015; 72(6):494-500. Bartlett D, Pang N, Massey C, Evans P. Pharmacists Consultations: simplifying daily drug regimens and providing education on fall risk for older adults. Consult Pharm. 2015; 30:141-52. Evans P, Aungst TD, Massey C, Bartlett D. Expanding clinical and information services to the ambulatory older adult through community outreach programs. Consult Pharm. 2015; 30(1):31-37.
32
Pharmacists Association Annual Meeting and Exposition. San Diego, CA. March 2015. Gravel TL, Morrill AM, Seed S, Lamson K. Enhancing veteran care: an interprofessional collaboration. MARLIN. Sutton, MA. March 2015. Ellis S, Lynch A, Charron D, Cabrera A. Veterinary Medicine in the Community Pharmacy: A Comparison of Pharmacist Knowledge and Veterinarian Expectations of Pharmacist Knowledge. American Pharmacists Association Annual Meeting and Exposition. San Diego, CA. March 2015. Mannville N, Frost K, Callahan C, Manferdini A, Minchella P, Todaro L, Sherriffs M, Horton ER. Utilizing Students and Technicians to Authorize Medication Refills through a Collaborative Practice. Pediatric Pharmacy Advocacy Group (PPAG) Annual Meeting. Minneapolis, MN. April/May 2015. Massey C, Aungst T, Evans P, Silva M. A Comprehensive Approach to Providing Medicare Part D Plan Evaluations: the MCPHS University Pharmacy Outreach experience. 2015 Aging in America Conference- American Society on Aging. Chicago, IL. March 2015. Mukherjee SM, Dietle AL, Dunican KC, Lynch AM, Lahoz MR. Patient Diabetes Medication Leaflets: Do They Effectively Inform and Enable Patients to Take Actions? American Pharmacists Association Annual Meeting and Exposition. San Diego, CA. March 2015.
Mukherjee SM, Copperrath VA, Dallinga BA. Pharmacologic management of types 1 and 2 diabetes mellitus and their complications in women of childbearing age. Pharmacotherapy. 2015; 30(2):158-174.
Sullivan K, Nemeth C, Pariseau J, Nguyen H, Blanchard G, Abraham G. Assessing the Utilization of a New Insomnia Order Set in a Community Hospital. National Patient Safety Foundation Annual Patient Safety Congress. Austin, TX. April 2015.
Poster Presentations
Promotions
Campanale M, Dietle A. A Retrospective Review of Prescription Monitoring Program Use by Pharmacists in a Community Health Center Outpatient Pharmacy. American Pharmacists Association Annual Meeting and Exposition. San Diego, CA. March 28, 2015.
Dr. Evan Horton promoted to Associate Professor of Pharmacy Practice
Dunican K, Cabrera A, Durand C, Conway S, Lynch A, Abel C, Towle J, Comee M. Implementation of Longitudinal Communication Experiences to Improve Confidence of Student Pharmacists in Patient Counseling. American
Dr. Monina R. Lahoz promoted to Professor of Pharmacy Administration Dr. Anna Morin promoted to Professor of Pharmacy Practice Dr. Helen Pervanas promoted to Associate Professor of Pharmacy
Pharmacy Journal of New England • Summer 2015
University of New England UNE College of Pharmacy granted fouryear accreditation The University Of New England College Of Pharmacy is pleased to announce that its Doctor of Pharmacy program has been granted an extended accreditation term until 2019 by the Accreditation Council for Pharmacy Education (ACPE). This news follows the program’s initial two-year accreditation, and is a result of the College’s clear mission, goals and program structure. According to ACPE, “…all health care professionals, pharmacists and pharmacy technicians must be educated to deliver patient-centered care as members of an interprofessional team, emphasizing evidence-based practice, quality improvement approaches and informatics.”
College of Pharmacy Measles Vaccination Clinic Appears on Bangor Daily News Spring Honors The measles vaccination clinic organized by UNE and Portland Community Health Center earlier this week caught the attention of the Bangor Daily News. Dora Anne Mills, M.D., M.P.H., F.A.A.P., vice president for clinical affairs, provided an interview for the article, revealing that Maine has one of the highest unvaccination rates in the country. She explained that it is much safer to begin vaccinating community members before an outbreak ocurs, and described the severity of measles symptoms. The article also included a video, documenting Kenneth McCall, BSPharm, Pharm.D., associate professor in the College of Pharmacy (COP), administering the vaccine to patients, with the help of COP students.
during the 2015 APhA Annual Meeting in San Diego. Dizon is one of only 13 recipients nationwide to receive this prestigious scholarship which recognizes leadership skills and academics through active involvement in the APhA Academy of Student Pharmacists. This distinguished scholarship is awarded annually to exceptional students who help shape the future of the pharmacy profession while managing the demands of a fulltime Doctor of Pharmacy curriculum.
Edward Li co-authors report in American Journal of Health-System Pharmacy Edward Li, Pharm.D., M.P.H., BCOP, associate professor in the UNE Department of Pharmacy Practice, co-authored the annual drug expenditure forecast report published by the American Journal of Health-System Pharmacy (AJHP). In his report, Li explained that prescription drug expenditures are expected to increase in the U.S. throughout 2015 due, in part, to specialty drugs. The rates of increase include: •
7-9% across all settings
•
12-14% in clinics
•
5-7 % in hospitals
Watch the Bangor Daily News segment
Read the full report online
Jessica Dizon receives American Pharmacists Association Foundation scholars
Greta Astrup selected for ASHP Student Leadership Award
Jessica Dizon, College of Pharmacy ’15, was selected by the American Pharmacists Association Foundation (APhA) to receive a 2015 student scholarship. She was recognized on March 30 at the APhA Foundation Contributors’ Breakfast
Greta Astrup, Class of 2015, has been selected as a 2014/2015 recipient of the ASHP Student Leadership Award.
33
From the Colleges
continued
This is the highest individual award ASHP recognizes and she is one of four Class of 2015 students in the nation to be a recipient. The award, sponsored by ASHP and the ASHP Research and Education Foundation, is given to student members in their second through fourth professional years of pharmacy school. It recognizes achievements in campus leadership and pharmacy practice in hospitals or ambulatory care clinics.
Edward Li and Lindsay Robusto selected as AACP Wal-Mart Scholar Program Recipients Edward Li, PharmD, M.P.H., BCOP, associate professor of Pharmacy Practice, and Lindsay Robusto, PharmD candidate ’16, were selected as 2015 American Association of Colleges of Pharmacy (AACP) Wal-Mart Scholar Program Recipients. Li and Robusto were among 85 people to receive $1,000 travel scholarships to attend the AACP Annual Meeting and the AACP Teachers’ Seminar in National Harbor, Maryland on July 11-15, 2015. The goal of the scholarship program is to strengthen recipients’ skills and commitment to a career in academic pharmacy through participation in programming and activities at the 2015 AACP Annual Meeting and Seminars.
Gayle Brazeau featured on ‘Pharmaphorum’ Gale Brazeau, Ph.D., Dean of the College of Pharmacy, recently spoke to pharmaphorum about pharmacogenomics in health care. In the interview, she explained the importance of using pharmacogenomics in inter-professional settings to improve patient outcomes. She also discussed the future of health care, her dedication to studentcentric education and UNE’s role in developing a positive, knowledgeable pharmacy community. Pharmaphorum is an online resource aiming to help healthcare stakeholders within the pharmaceutical industry communicate, connect and collaborate to drive medical innovation and deliver better outcomes for patients.
UNE students take home third place at CLARION competition UNE’s interprofessional student team placed third out of 15 participating teams at the National CLARION Interprofessional Case Competition on April 17–18 in Minneapolis, Minnesota. Members of the team included: •
Julet Baltonado, College of Osteopathic Medicine
Olgun Guvench receives Faculty Early Career Development grant
•
Stephanie Brown, College of Pharmacy
•
Erin Kany, College of Pharmacy
Olgun Guvench, M.D., Ph.D., assistant professor and vice-chair in the Department of Pharmaceutical Sciences is a recipient of a Faculty Early Career Development grant for a proposed project entitled, “Atomic resolution modeling of proteoglycans.”
•
Jenny Ottoson, Physicians Assistant Program
The CAREER grant is the National Science Foundation’s most prestigious award in support of junior faculty who exemplify the role of teacher-scholars through outstanding research, excellent education and the integration of education and research within the context of the mission of their organizations. 34
The grant will run from May 2015 through 2019.
These students were advised by Rebecca Boulos, M.P.H., Ph.D., assistant clinical professor in the School of Community and Population Health; Jeff Nevers, M.A., affiliated professor in the Department of Physical Therapy; and Lisa Pagnucco, B.S. Pharm, Pharm.D., BCACP, assistant professor in the Department of Pharmacy Practice. The CLARION competition is an event hosted by the University of Minnesota, dedicated to furthering interprofessional collab-
Pharmacy Journal of New England • Summer 2015
oration for improving patient safety and health care quality. During the competition, student teams of four are asked to analyze a medical case for a panel of judges. They are evaluated based on real-world standards of practice. President Danielle Ripich commented, “This great showing is a marker of excellence that builds the reputation of our university as an innovative health sciences institution. These students are the future thought leaders in medical care and I couldn’t be more proud of them.”
Analesa Muir and Tyson Fredriksen elected to regional offices during the Northeast Province Assembly Two UNE students in the College of Pharmacy were elected to regional offices during the Northeast Province Assembly hosted by the Nu Chapter of Kappa Psi at the University of Connecticut: • Analesa Muir was elected to the office of Province Secretary • Tyson Fredriksen was elected as Province Chaplain The Northeast Province of Kappa Psi Pharmaceutical Fraternity is one of 11 geographical-based regions helping to facilitate communication and fellowship between chapters. The Northeast Province Assembly meets twice yearly to facilitate its mission and to support the brothers of the area through education and networking. As Province Secretary, Muir will act as the main contact person for the regional officers of the 10 collegiate chapters and the 12 graduate chapters of the Northeast Province, including Maine, New Hampshire, Vermont, Rhode Island, Connecticut, Eastern New York, New Jersey and Eastern Pennsylvania.
As Province Chaplain, Fredriksen is charged with helping chapters within the Northeast Province conduct the rituals of the organization and help lead philanthropic efforts for the Province. The Northeast Province Assembly also recognized fourth-year Pharmacy student Sarah Pollack for completing her term as Province Historian. Pollack was responsible for helping chapters record their history in an organized fashion. She also left a record of the province’s history and submitted quarterly articles to the official Kappa Psi Journal, “The Mask.” Matthew Lacroix, Pharm.D., BCPS, assistant professor in the College of Pharmacy, served as the regional president, or The Province Satrap of the Northeast Province. He has been responsible for chairing the Executive Committee of the Province, as well as leading the province assembly meetings and the general functioning of the region.
Edward Li publishes papers on biosimilars, referenced in ‘Pharmacy Times’ Edward C. Li, Pharm.D., M.P.H., BCOP, associate professor in the College of Pharmacy, recently published several papers on the growing global interest of biosimilar products in the health care community. His latest paper, “Pharmacist Substitution of Biological Products: Issues and Considerations,” was published in the July 2015 edition of the Journal of Managed Care & Specialty Pharmacy, and was referenced in a Pharmacy Times article. In his paper, Li outlines why it is important for pharmacists and the community to be aware of the differences between generic and biosimilar medication, which are similar but not identical to brand-name medications. He explains that pharmacists need to be knowledgeable about specific state-requirements regarding the dispensing of biosimilars in pharmacy settings.
35
From the Colleges
continued
Li also recently discussed biosimilars in two other published papers:
• She is a graduating student from the College of Pharmacy Class of 2015
• “Considerations in the Early Development of Biosimilar Products,” published in the May 2015 issue of Drug Discovery Today.
• She placed within the top 25 percent of her class academically and plans to enter the pharmacy practice following graduation
• “Development of Biosimilars in an Era of Oncologic Drug Shortages,” published in Volume 9, 2015 of Drug Design, Development and Therapy.
• She has demonstrated high personal motivation and possesses a unique ability to communicate drug information
Olgun Guvench to present poster in South Korea Olgun Guvench, Ph.D., assistant professor in the Department of Pharmaceutical Sciences, and UNE Pharmacy students Hoang Pharm and Cathy Ng developed a poster presentation titled, “Conformational Properties of the Glycosidic Linkages in Dermatan Sulfate Versus Chondroitin Sulfate as Determined by Molecular Simulation.” The presentation discusses how computer simulations are applied to understand the structure of carbohydrates that help cells adhere to each other to form tissues and organs. Guvench presented this poster at the 9th International Conference on Proteoglycans on August 23–27, in Seoul, South Korea.
Donna Park receives Mylan Pharmaceuticals Excellence in Pharmacy Award Donna Park, Pharm.D. ’15, was presented with the Mylan Pharmaceuticals Excellence in Pharmacy Award at the Graduating Class Awards Night on May 13, 2015, at the Masonic Temple in Portland, Maine. The Mylan Excellence in Pharmacy Award is presented annually to a student who demonstrates superior proficiency in the provision of drug information services. Park was selected for this honor based on several criteria: 36
Feature: Vaccine Therapy Strides Forward References, continued 5. Centers for Disease Control and Prevention (CDC). Update on Recommendations for Use of Herpes Zoster Vaccine. MMWR Morb Mortal Wkly Rep. 2014; 63(33):729-731. 6. Oxman MN, Levin MJ, Johnson GR, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005;352:2271–84. 7. Schmader KE, Oxman MN, Levin MJ, et al. Persistence of the efficacy of zoster vaccine in the shingles prevention study and the short-term persistence substudy. Clin Infect Dis 2012;55:1320–8. 8. Gardasil 9 (Human Papillomavirus 9-valent Vaccine, Recombinant) [package insert]. Whitehouse, NJ: Merck Co; Revised December 2014. 9. Use of 9-Valent Human Papillomavirus (HPV) Vaccine: Updated HPV Vaccination Recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 2015; 64(11):300-304. 10. Bexsero (Meningococcal Group B Vaccine) [package insert]. Sovicille, Italy: Novartis Vaccines and Diagnostics S.r.l. 2015. 11. Trumenba (Meningococcal Group B Vaccine) [package insert]. Philadelphia, PA: Wyeth Pharmaceuticals Inc. 2015. 12. Folaranmi T, Rubin L, Martin SW, Patel M, MacNeil JR. Use of Serogroup B Meningococcal Vaccines in Persons Aged ≥10 Years at Increased Risk for Serogroup B Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices, 2015. MMWR Morb Mortal Wkly Rep. 2015 Jun 12;64(22):608-12. 13. NFID. The long and winding road to meningococcal serogroup B vaccine recommendations. Accessed on nfid.wordpress.com on June 24, 2015.
Pharmacy Journal of New England • Summer 2015
University of St. Joseph School of Pharmacy Message from the Dean Sincere salutations from us to you. I am pleased to inform you that another class of pharmacy students has graduated with their Doctor of Pharmacy degrees from University of Saint Joseph School of Pharmacy. Our graduates and proud USJ alumni have accepted offers throughout the country in various pharmacy practices, residencies and other post-graduate training. We expect great things and much success from them in the future. As always, we thank you for your continued support. Best, Joseph Ofosu Dean, University of Saint Joseph School of Pharmacy
New Appointments Michele Riccardi, Pharm.D., BCPS, Assistant Professor, Department of Pharmacy Practice and Administration Dr. Riccardi received her bachelor degree in pharmacy at St. John’s University in NY. After practicing pharmacy for 9 years she went back to college to receive her Pharm.D from Massachusetts College of Pharmacy. Her experience as a pharmacist includes, retail, long term care, psychiatry and acute care. She has been practicing as a Pharmacy Clinical Coordinator at MidState Medical Center for the past 15 years. Dr. Riccardi’s biggest passion is teaching. She taught pharmacology to physician assistant students at Quinnipiac University and has also been a preceptor for several pharmacy schools for 15 years.
Second Class Graduates The Hooding, Oath and Awards Ceremony for the inaugural Doctor of Pharmacy Class of the University of Saint Joseph was held on Friday, May 8, 2015 at the Hoffman Auditorium of the Bruyette Athenaeum on the main campus of the University. The sixty-nine graduates were assisted in donning their doctoral hoods by members of the School of Pharmacy
faculty. They were then lead in reciting the Pharmacist’s Oath by Dean Joseph R. Ofosu. Eighteen awards were presented to members of the class in recognition of their service, leadership and academic achievement, and the officers of the Class of 2015 presented a gift to the School of Pharmacy. The Marguerite M. Miceli Memorial Award has been established in memory of Ms. Marguerite M. Miceli who would have been part of the graduating Class of 2015. This award will be issued annually to two graduating students who have made significant improvements in academic performance in the pharmacy program and have demonstrated sound character and true passion for a career in pharmacy. The two recipients for 2015 were Anissa Turner and Jetun Patel. It was a special moment for the entire student body and all that were in attendance. The ceremony was followed by a reception.
Graduate Featured Anissa Turner, a Class of 2015 graduate, was featured in an article in the New London Day (May 24, 2015). The article exudes the character of a young woman who is determined to succeed, and primed for the pharmacy profession. The full article can be found at: http://www.theday.com/article/20150524/NWS01/150529554
Posters and Presentations Ghoneim OM, Dhuguru J, Soldato DE, Edafiogho IO. ”Structure Activity Relationship of Novel Piperazino Enaminones as Potential Anti-inflammatory Agents.” Accepted for Poster Presentation, American Association of Colleges of Pharmacy (AACP) Annual Meeting, National Harbor, Baltimore MD, July 11-15, 2015. Edafiogho IO, Ghoneim OM, Sweezy MA, Howard HR. ”Synthesis and Evaluation of Imidooxy Compounds as Potential Anticancer Agents.” Accepted for Poster Presentation, American Association of Colleges of Pharmacy (AACP) Annual Meeting, National Harbor, Baltimore MD, July 11-15, 2015. 37
From the Colleges
continued
Soldato DE, Luciano J, Laskey DA, ”Assessing Critical Thinking through Writing in a Three Calendar Year Pharmacy Curriculum.” Accepted for Poster Presentation, American Association of Colleges of Pharmacy (AACP) Annual Meeting, National Harbor, Baltimore MD, July 11-15, 2015. Leschak A and Hattoy S. “Dangers of Mixing Alcohol with Over the Counter Medications and Food-Drug Interactions” at the Metropolitan AME Zion Church in Hartford, CT on June 18th (Audience: Approximately 50-75 people over the age of 60). Leschak A. “Dangers of Mixing Alcohol with Over the Counter Medications and Food-Drug Interactions” at the Madison Police Department and Madison Senior Center May 13, 2015, Madison, CT.
Pulmonary Embolism All-Cause Mortality: A Bivariate MetaAnalysis.” Chest. 2015 April 1;147(4):1043-62 Mearns ES, Coleman CI, Patel D, Saulsberry WJ, Corman A, Li D, Hernandez AV, Kohn CG. “Index clinical manifestation of venous thromboembolism predicts early recurrence type and frequency: a meta-analysis of randomized controlled trials.” J Thromb Haemost. 2015 Mar 28. [Epub ahead of print] Laskey, DA “Vitamin A: A historical Poison in the Most Unlikely of Places”, History of Pharmacy SIG Newsletter - Pharmacy Chronicles: Past, Present and Future, Spring 2015 Laskey DA “The Medicine Garden: Reminiscent of Pharmacognosy Days”, History of Pharmacy SIG Newsletter Pharmacy Chronicles: Past, Present and Future, Spring 2015
Cappelluti E, Reardon J, Ewing C. “COPD: Tackling the Transition” at the Schwarting Senior Symposium, March 17, 2015, Aqua Turf Club, Plantsville, CT. Hattoy S, Eisenhower C. “New Drug Update” at the Schwarting Senior Symposium, March 17, 2015, Aqua Turf Club, Plantsville, CT.
Honors and Accomplishments: Drs. Dora Wiskirchen, Lisa DeGennaro, and Andrea Leschak, completed the National Association of Chain Drug Stores Community Pharmacy-based Point-of-Care Testing Certificate Course in Boston, MA in May 2015.
Publications Kohn CG, Mearns EL, Parker MW, Hernandez AV, Coleman CI. “Prognostic Accuracy of Clinical Prediction Rules for Early Post-
Please let us know if you have news or a feature article to submit for a future issue of the
Pharmacy Journal of New England Contact: kellis@masspharmacists.org
38
39